<!DOCTYPE html>
<html lang="en"><head>
<script src="Lecture1_files/libs/clipboard/clipboard.min.js"></script>
<script src="Lecture1_files/libs/quarto-html/tabby.min.js"></script>
<script src="Lecture1_files/libs/quarto-html/popper.min.js"></script>
<script src="Lecture1_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="Lecture1_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="Lecture1_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<link href="Lecture1_files/libs/quarto-contrib/fontawesome6-0.1.0/all.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-contrib/fontawesome6-0.1.0/latex-fontsize.css" rel="stylesheet">
<script src="Lecture1_files/libs/quarto-contrib/glightbox/glightbox.min.js"></script>
<link href="Lecture1_files/libs/quarto-contrib/glightbox/glightbox.min.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-contrib/glightbox/lightbox.css" rel="stylesheet"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.5.54">

  <title>lecture1</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="Lecture1_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="Lecture1_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
    /* CSS for citations */
    div.csl-bib-body { }
    div.csl-entry {
      clear: both;
      margin-bottom: 0em;
    }
    .hanging-indent div.csl-entry {
      margin-left:2em;
      text-indent:-2em;
    }
    div.csl-left-margin {
      min-width:2em;
      float:left;
    }
    div.csl-right-inline {
      margin-left:2em;
      padding-left:1em;
    }
    div.csl-indent {
      margin-left: 2em;
    }  </style>
  <link rel="stylesheet" href="Lecture1_files/libs/revealjs/dist/theme/quarto.css">
  <link href="Lecture1_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-chalkboard/font-awesome/css/all.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-chalkboard/style.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-pointer/pointer.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    padding-bottom: 0.5rem;
    margin-bottom: 0;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">


<section id="lecture-1-overview-of-antibiotic-therapy-general-principles" class="slide level2" data-background-video="/images/bacteria.mp4" data-background-video-loop="true" data-background-video-muted="true">
<h2>Lecture 1: Overview of Antibiotic Therapy: <br> General principles</h2>
<p><br> <br> <br> <br></p>
<p><strong>Russell E. Lewis</strong> <br> Associate Professor of Infectious Diseases <br> Department of Molecular Medicine <br> University of Padua</p>
<p><br> <i class="fa-solid fa-envelope fa-1x" aria-label="envelope"></i> russelledward.lewis@unipd.it <br> <i class="fa-brands fa-github fa-1x" aria-label="github"></i> <a href="https://github.com/Russlewisbo/ESCMID_2022_talk">https://github.com/Russlewisbo</a></p>
<p><a href="University_of_Padua_seal.svg" class="lightbox" data-gallery="quarto-lightbox-gallery-1"><img data-src="University_of_Padua_seal.svg" class="absolute" style="top: 550px; left: 150px; width: 150px; height: 100px; "></a></p>
</section>
<section id="agenda" class="slide level2">
<h2>Agenda</h2>
<p><br></p>
<ul>
<li>Key pharmacokinetic (PK) parameters of antibiotics</li>
<li>Pharmacodynamic (PD) patterns of antibiotics
<ul>
<li>How can PD be determined pre-clinically and optimised clinically?</li>
</ul></li>
<li>How can PK/PD information individualise patient therapy?</li>
<li>Combination antibiotic therapy</li>
</ul>
</section>
<section id="pharmacokinetics-and-pharmacodynamics" class="slide level2 smaller">
<h2>Pharmacokinetics and Pharmacodynamics</h2>
<div class="cell" data-layout-align="default">
<div class="cell-output-display">
<div>
<p></p><figure class=""><p></p>
<div>
<svg width="960" height="480" viewbox="0.00 0.00 633.69 332.00" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" style="; max-width: none; max-height: none; display: block; margin: auto auto auto auto">
<g id="graph0" class="graph" transform="scale(1 1) rotate(0) translate(4 328)">
<title>G</title>
<polygon fill="white" stroke="transparent" points="-4,4 -4,-328 629.69,-328 629.69,4 -4,4"></polygon>
<!-- patient -->
<g id="node1" class="node">
<title>patient</title>
<text text-anchor="middle" x="48.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Patient factors</text>
</g>
<!-- PK -->
<g id="node2" class="node">
<title>PK</title>
<ellipse fill="none" stroke="black" cx="157.24" cy="-234" rx="100.75" ry="18"></ellipse>
<text text-anchor="middle" x="157.24" y="-229.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacokinetics (PK)</text>
</g>
<!-- patient&#45;&gt;PK -->
<g id="edge1" class="edge">
<title>patient-&gt;PK</title>
<path fill="none" stroke="black" d="M74.9,-287.88C89.34,-278.61 107.33,-267.05 122.82,-257.1"></path>
<polygon fill="black" stroke="black" points="125.07,-259.81 131.6,-251.47 121.29,-253.92 125.07,-259.81"></polygon>
</g>
<!-- PKPD -->
<g id="node8" class="node">
<title>PKPD</title>
<ellipse fill="none" stroke="black" cx="270.24" cy="-162" rx="38.32" ry="18"></ellipse>
<text text-anchor="middle" x="270.24" y="-157.8" font-family="Lato,Arial,sans-serif" font-size="14.00">PK/PD</text>
</g>
<!-- PK&#45;&gt;PKPD -->
<g id="edge6" class="edge">
<title>PK-&gt;PKPD</title>
<path fill="none" stroke="black" d="M183.73,-216.59C200.39,-206.26 221.97,-192.9 239.4,-182.1"></path>
<polygon fill="black" stroke="black" points="241.43,-184.96 248.09,-176.72 237.75,-179.01 241.43,-184.96"></polygon>
</g>
<!-- drug -->
<g id="node3" class="node">
<title>drug</title>
<text text-anchor="middle" x="157.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Drug factors</text>
</g>
<!-- drug&#45;&gt;PK -->
<g id="edge2" class="edge">
<title>drug-&gt;PK</title>
<path fill="none" stroke="black" d="M157.24,-287.7C157.24,-279.98 157.24,-270.71 157.24,-262.11"></path>
<polygon fill="black" stroke="black" points="160.74,-262.1 157.24,-252.1 153.74,-262.1 160.74,-262.1"></polygon>
</g>
<!-- intrinsic -->
<g id="node4" class="node">
<title>intrinsic</title>
<text text-anchor="middle" x="279.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Intrinsic resistance</text>
</g>
<!-- PD -->
<g id="node5" class="node">
<title>PD</title>
<ellipse fill="none" stroke="black" cx="402.24" cy="-234" rx="107.7" ry="18"></ellipse>
<text text-anchor="middle" x="402.24" y="-229.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacodynamics (PD)</text>
</g>
<!-- intrinsic&#45;&gt;PD -->
<g id="edge3" class="edge">
<title>intrinsic-&gt;PD</title>
<path fill="none" stroke="black" d="M309.33,-287.88C325.92,-278.43 346.69,-266.61 364.37,-256.55"></path>
<polygon fill="black" stroke="black" points="366.34,-259.45 373.3,-251.47 362.88,-253.37 366.34,-259.45"></polygon>
</g>
<!-- PD&#45;&gt;PKPD -->
<g id="edge7" class="edge">
<title>PD-&gt;PKPD</title>
<path fill="none" stroke="black" d="M371.29,-216.59C351.07,-205.86 324.66,-191.86 303.92,-180.86"></path>
<polygon fill="black" stroke="black" points="305.3,-177.63 294.82,-176.04 302.02,-183.82 305.3,-177.63"></polygon>
</g>
<!-- acquired -->
<g id="node6" class="node">
<title>acquired</title>
<text text-anchor="middle" x="421.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Acquired resistance</text>
</g>
<!-- acquired&#45;&gt;PD -->
<g id="edge4" class="edge">
<title>acquired-&gt;PD</title>
<path fill="none" stroke="black" d="M416.54,-287.7C414.42,-279.9 411.87,-270.51 409.52,-261.83"></path>
<polygon fill="black" stroke="black" points="412.88,-260.84 406.88,-252.1 406.12,-262.67 412.88,-260.84"></polygon>
</g>
<!-- inoculum -->
<g id="node7" class="node">
<title>inoculum</title>
<text text-anchor="middle" x="564.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Infection inoculum</text>
</g>
<!-- inoculum&#45;&gt;PD -->
<g id="edge5" class="edge">
<title>inoculum-&gt;PD</title>
<path fill="none" stroke="black" d="M524.61,-287.88C501.62,-277.94 472.55,-265.38 448.52,-255"></path>
<polygon fill="black" stroke="black" points="449.8,-251.74 439.24,-250.99 447.03,-258.17 449.8,-251.74"></polygon>
</g>
<!-- microbiological -->
<g id="node9" class="node">
<title>microbiological</title>
<polygon fill="none" stroke="black" points="349.14,-108 191.33,-108 191.33,-72 349.14,-72 349.14,-108"></polygon>
<text text-anchor="middle" x="270.24" y="-85.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Microbiological outcome</text>
</g>
<!-- PKPD&#45;&gt;microbiological -->
<g id="edge8" class="edge">
<title>PKPD-&gt;microbiological</title>
<path fill="none" stroke="black" d="M270.24,-143.7C270.24,-135.98 270.24,-126.71 270.24,-118.11"></path>
<polygon fill="black" stroke="black" points="273.74,-118.1 270.24,-108.1 266.74,-118.1 273.74,-118.1"></polygon>
</g>
<!-- clinical -->
<g id="node10" class="node">
<title>clinical</title>
<polygon fill="none" stroke="black" points="326.27,-36 214.21,-36 214.21,0 326.27,0 326.27,-36"></polygon>
<text text-anchor="middle" x="270.24" y="-13.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Clinical outcome</text>
</g>
<!-- microbiological&#45;&gt;clinical -->
<g id="edge9" class="edge">
<title>microbiological-&gt;clinical</title>
<path fill="none" stroke="black" d="M270.24,-71.7C270.24,-63.98 270.24,-54.71 270.24,-46.11"></path>
<polygon fill="black" stroke="black" points="273.74,-46.1 270.24,-36.1 266.74,-46.1 273.74,-46.1"></polygon>
</g>
</g>
</svg>
</div>
<p></p></figure><p></p>
</div>
</div>
</div>

<aside><div>
<p><span class="citation" data-cites="theuretzbacher2012">(<a href="#/references" role="doc-biblioref" onclick="">Theuretzbacher, 2012</a>)</span></p>
</div></aside></section>
<section id="pharmacokinetics-and-pharmacodynamics-1" class="slide level2 smaller">
<h2>Pharmacokinetics and Pharmacodynamics</h2>
<div class="cell" data-layout-align="default">
<div class="cell-output-display">
<div>
<p></p><figure class=""><p></p>
<div>
<svg width="960" height="480" viewbox="0.00 0.00 633.69 332.00" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" style="; max-width: none; max-height: none; display: block; margin: auto auto auto auto">
<g id="graph0" class="graph" transform="scale(1 1) rotate(0) translate(4 328)">
<title>G</title>
<polygon fill="white" stroke="transparent" points="-4,4 -4,-328 629.69,-328 629.69,4 -4,4"></polygon>
<!-- patient -->
<g id="node1" class="node">
<title>patient</title>
<text text-anchor="middle" x="48.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Patient factors</text>
</g>
<!-- PK -->
<g id="node2" class="node">
<title>PK</title>
<ellipse fill="none" stroke="black" cx="157.24" cy="-234" rx="100.75" ry="18"></ellipse>
<text text-anchor="middle" x="157.24" y="-229.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacokinetics (PK)</text>
</g>
<!-- patient&#45;&gt;PK -->
<g id="edge1" class="edge">
<title>patient-&gt;PK</title>
<path fill="none" stroke="black" d="M74.9,-287.88C89.34,-278.61 107.33,-267.05 122.82,-257.1"></path>
<polygon fill="black" stroke="black" points="125.07,-259.81 131.6,-251.47 121.29,-253.92 125.07,-259.81"></polygon>
</g>
<!-- PKPD -->
<g id="node8" class="node">
<title>PKPD</title>
<ellipse fill="yellow" stroke="black" cx="270.24" cy="-162" rx="38.32" ry="18"></ellipse>
<text text-anchor="middle" x="270.24" y="-157.8" font-family="Lato,Arial,sans-serif" font-size="14.00">PK/PD</text>
</g>
<!-- PK&#45;&gt;PKPD -->
<g id="edge6" class="edge">
<title>PK-&gt;PKPD</title>
<path fill="none" stroke="black" d="M183.73,-216.59C200.39,-206.26 221.97,-192.9 239.4,-182.1"></path>
<polygon fill="black" stroke="black" points="241.43,-184.96 248.09,-176.72 237.75,-179.01 241.43,-184.96"></polygon>
</g>
<!-- drug -->
<g id="node3" class="node">
<title>drug</title>
<text text-anchor="middle" x="157.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Drug factors</text>
</g>
<!-- drug&#45;&gt;PK -->
<g id="edge2" class="edge">
<title>drug-&gt;PK</title>
<path fill="none" stroke="black" d="M157.24,-287.7C157.24,-279.98 157.24,-270.71 157.24,-262.11"></path>
<polygon fill="black" stroke="black" points="160.74,-262.1 157.24,-252.1 153.74,-262.1 160.74,-262.1"></polygon>
</g>
<!-- intrinsic -->
<g id="node4" class="node">
<title>intrinsic</title>
<text text-anchor="middle" x="279.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Intrinsic resistance</text>
</g>
<!-- PD -->
<g id="node5" class="node">
<title>PD</title>
<ellipse fill="none" stroke="black" cx="402.24" cy="-234" rx="107.7" ry="18"></ellipse>
<text text-anchor="middle" x="402.24" y="-229.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacodynamics (PD)</text>
</g>
<!-- intrinsic&#45;&gt;PD -->
<g id="edge3" class="edge">
<title>intrinsic-&gt;PD</title>
<path fill="none" stroke="black" d="M309.33,-287.88C325.92,-278.43 346.69,-266.61 364.37,-256.55"></path>
<polygon fill="black" stroke="black" points="366.34,-259.45 373.3,-251.47 362.88,-253.37 366.34,-259.45"></polygon>
</g>
<!-- PD&#45;&gt;PKPD -->
<g id="edge7" class="edge">
<title>PD-&gt;PKPD</title>
<path fill="none" stroke="black" d="M371.29,-216.59C351.07,-205.86 324.66,-191.86 303.92,-180.86"></path>
<polygon fill="black" stroke="black" points="305.3,-177.63 294.82,-176.04 302.02,-183.82 305.3,-177.63"></polygon>
</g>
<!-- acquired -->
<g id="node6" class="node">
<title>acquired</title>
<text text-anchor="middle" x="421.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Acquired resistance</text>
</g>
<!-- acquired&#45;&gt;PD -->
<g id="edge4" class="edge">
<title>acquired-&gt;PD</title>
<path fill="none" stroke="black" d="M416.54,-287.7C414.42,-279.9 411.87,-270.51 409.52,-261.83"></path>
<polygon fill="black" stroke="black" points="412.88,-260.84 406.88,-252.1 406.12,-262.67 412.88,-260.84"></polygon>
</g>
<!-- inoculum -->
<g id="node7" class="node">
<title>inoculum</title>
<text text-anchor="middle" x="564.24" y="-301.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Infection inoculum</text>
</g>
<!-- inoculum&#45;&gt;PD -->
<g id="edge5" class="edge">
<title>inoculum-&gt;PD</title>
<path fill="none" stroke="black" d="M524.61,-287.88C501.62,-277.94 472.55,-265.38 448.52,-255"></path>
<polygon fill="black" stroke="black" points="449.8,-251.74 439.24,-250.99 447.03,-258.17 449.8,-251.74"></polygon>
</g>
<!-- microbiological -->
<g id="node9" class="node">
<title>microbiological</title>
<polygon fill="none" stroke="black" points="349.14,-108 191.33,-108 191.33,-72 349.14,-72 349.14,-108"></polygon>
<text text-anchor="middle" x="270.24" y="-85.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Microbiological outcome</text>
</g>
<!-- PKPD&#45;&gt;microbiological -->
<g id="edge8" class="edge">
<title>PKPD-&gt;microbiological</title>
<path fill="none" stroke="black" d="M270.24,-143.7C270.24,-135.98 270.24,-126.71 270.24,-118.11"></path>
<polygon fill="black" stroke="black" points="273.74,-118.1 270.24,-108.1 266.74,-118.1 273.74,-118.1"></polygon>
</g>
<!-- clinical -->
<g id="node10" class="node">
<title>clinical</title>
<polygon fill="none" stroke="black" points="326.27,-36 214.21,-36 214.21,0 326.27,0 326.27,-36"></polygon>
<text text-anchor="middle" x="270.24" y="-13.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Clinical outcome</text>
</g>
<!-- microbiological&#45;&gt;clinical -->
<g id="edge9" class="edge">
<title>microbiological-&gt;clinical</title>
<path fill="none" stroke="black" d="M270.24,-71.7C270.24,-63.98 270.24,-54.71 270.24,-46.11"></path>
<polygon fill="black" stroke="black" points="273.74,-46.1 270.24,-36.1 266.74,-46.1 273.74,-46.1"></polygon>
</g>
</g>
</svg>
</div>
<p></p></figure><p></p>
</div>
</div>
</div>
<p><br></p>
<center>
<em>Doses can be adjusted to improved the probability of microbiological outcomes!</em>
</center>

<aside><div>
<p><span class="citation" data-cites="theuretzbacher2012">(<a href="#/references" role="doc-biblioref" onclick="">Theuretzbacher, 2012</a>)</span></p>
</div></aside></section>
<section id="pharmacology-of-antimicrobials" class="slide level2 smaller">
<h2>Pharmacology of antimicrobials</h2>
<div class="cell" data-layout-align="default">
<div class="cell-output-display">
<div>
<p></p><figure class=""><p></p>
<div>
<svg width="960" height="480" viewbox="0.00 0.00 586.13 250.40" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" style="; max-width: none; max-height: none; display: block; margin: auto auto auto auto">
<g id="graph0" class="graph" transform="scale(1 1) rotate(0) translate(4 246.4)">
<title>G</title>
<polygon fill="white" stroke="transparent" points="-4,4 -4,-246.4 582.13,-246.4 582.13,4 -4,4"></polygon>
<g id="clust1" class="cluster">
<title>cluster_0</title>
<polygon fill="lightblue" stroke="lightblue" points="8,-75.4 8,-234.4 397.89,-234.4 397.89,-75.4 8,-75.4"></polygon>
<text text-anchor="middle" x="202.95" y="-217.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacokinetics (PK)</text>
</g>
<g id="clust2" class="cluster">
<title>cluster_1</title>
<polygon fill="lightblue" stroke="lightblue" points="417.89,-79.4 417.89,-222.4 574.13,-222.4 574.13,-79.4 417.89,-79.4"></polygon>
<text text-anchor="middle" x="496.01" y="-205.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacodynamics (PD)</text>
</g>
<!-- start -->
<g id="node1" class="node">
<title>start</title>
<polygon fill="white" stroke="white" points="121.73,-156.4 16.09,-156.4 16.09,-120.4 121.73,-120.4 121.73,-156.4"></polygon>
<text text-anchor="middle" x="68.91" y="-134.2" font-family="Lato,Arial,sans-serif" font-size="14.00">Dosing regimen</text>
</g>
<!-- dosing -->
<g id="node2" class="node">
<title>dosing</title>
<polygon fill="yellow" stroke="yellow" points="254.55,-159 157.57,-159 157.57,-117.8 254.55,-117.8 254.55,-159"></polygon>
<text text-anchor="middle" x="206.06" y="-142.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="206.06" y="-125.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> time in serum</text>
<text text-anchor="middle" x="122.23" y="-105" font-family="Lato,Arial,sans-serif" font-size="14.00"> </text>
<text text-anchor="middle" x="122.23" y="-88.2" font-family="Lato,Arial,sans-serif" font-size="14.00"> &nbsp;&nbsp;&nbsp;</text>
<text text-anchor="middle" x="122.23" y="-71.4" font-family="Lato,Arial,sans-serif" font-size="14.00"> &nbsp;</text>
<text text-anchor="middle" x="122.23" y="-54.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Absorption </text>
<text text-anchor="middle" x="122.23" y="-37.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Distribution </text>
<text text-anchor="middle" x="122.23" y="-21" font-family="Lato,Arial,sans-serif" font-size="14.00">Metabolism </text>
<text text-anchor="middle" x="122.23" y="-4.2" font-family="Lato,Arial,sans-serif" font-size="14.00">Elimination</text>
</g>
<!-- start&#45;&gt;dosing -->
<g id="edge1" class="edge">
<title>start-&gt;dosing</title>
<path fill="none" stroke="black" d="M121.78,-138.4C130.14,-138.4 138.84,-138.4 147.33,-138.4"></path>
<polygon fill="black" stroke="black" points="147.54,-141.9 157.54,-138.4 147.54,-134.9 147.54,-141.9"></polygon>
</g>
<!-- tissue -->
<g id="node3" class="node">
<title>tissue</title>
<polygon fill="white" stroke="white" points="387.26,-125 292.94,-125 292.94,-83.8 387.26,-83.8 387.26,-125"></polygon>
<text text-anchor="middle" x="340.1" y="-108.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="340.1" y="-91.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> time in tissue</text>
</g>
<!-- dosing&#45;&gt;tissue -->
<g id="edge2" class="edge">
<title>dosing-&gt;tissue</title>
<path fill="none" stroke="black" d="M254.36,-126.22C263.58,-123.85 273.34,-121.33 282.83,-118.89"></path>
<polygon fill="black" stroke="black" points="283.76,-122.26 292.58,-116.38 282.02,-115.48 283.76,-122.26"></polygon>
</g>
<!-- infection -->
<g id="node4" class="node">
<title>infection</title>
<polygon fill="white" stroke="white" points="389.69,-201.8 290.51,-201.8 290.51,-143 389.69,-143 389.69,-201.8"></polygon>
<text text-anchor="middle" x="340.1" y="-185" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="340.1" y="-168.2" font-family="Lato,Arial,sans-serif" font-size="14.00"> time at site of </text>
<text text-anchor="middle" x="340.1" y="-151.4" font-family="Lato,Arial,sans-serif" font-size="14.00"> infection</text>
</g>
<!-- dosing&#45;&gt;infection -->
<g id="edge3" class="edge">
<title>dosing-&gt;infection</title>
<path fill="none" stroke="black" d="M254.36,-150.58C262.85,-152.77 271.8,-155.07 280.56,-157.33"></path>
<polygon fill="black" stroke="black" points="279.8,-160.74 290.35,-159.85 281.54,-153.96 279.8,-160.74"></polygon>
</g>
<!-- PD1 -->
<g id="node5" class="node">
<title>PD1</title>
<polygon fill="white" stroke="white" points="562.25,-129 429.77,-129 429.77,-87.8 562.25,-87.8 562.25,-129"></polygon>
<text text-anchor="middle" x="496.01" y="-112.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacological or &nbsp;</text>
<text text-anchor="middle" x="496.01" y="-95.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> toxicological effect</text>
</g>
<!-- tissue&#45;&gt;PD1 -->
<g id="edge4" class="edge">
<title>tissue-&gt;PD1</title>
<path fill="none" stroke="black" d="M387.28,-105.6C397.51,-105.87 408.62,-106.15 419.68,-106.44"></path>
<polygon fill="black" stroke="black" points="419.72,-109.94 429.8,-106.71 419.9,-102.95 419.72,-109.94"></polygon>
</g>
<!-- PD2 -->
<g id="node6" class="node">
<title>PD2</title>
<polygon fill="white" stroke="white" points="560.52,-189 431.51,-189 431.51,-147.8 560.52,-147.8 560.52,-189"></polygon>
<text text-anchor="middle" x="496.01" y="-172.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Antimicrobal effect </text>
<text text-anchor="middle" x="496.01" y="-155.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> vs. time</text>
</g>
<!-- infection&#45;&gt;PD2 -->
<g id="edge5" class="edge">
<title>infection-&gt;PD2</title>
<path fill="none" stroke="black" d="M389.8,-171.13C399.81,-170.87 410.56,-170.59 421.23,-170.32"></path>
<polygon fill="black" stroke="black" points="421.5,-173.81 431.41,-170.05 421.32,-166.81 421.5,-173.81"></polygon>
</g>
</g>
</svg>
</div>
<p></p></figure><p></p>
</div>
</div>
</div>

<aside><div>
<p><span class="citation" data-cites="craig_1998">(<a href="#/references" role="doc-biblioref" onclick="">Craig, 1998</a>)</span></p>
</div></aside></section>
<section id="antibiotic-pharmacokinetics-are-described-by-concentration-time-curves-in-serum" class="slide level2 smaller">
<h2>Antibiotic pharmacokinetics are described by concentration-time curves in serum</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/pk%20principles.png" class="lightbox" data-gallery="quarto-lightbox-gallery-2"><img data-src="images/pk%20principles.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
</section>
<section id="oral-is-the-new-iv" class="slide level2">
<h2>Oral is the new IV…</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/orlaiv.png" class="lightbox" data-gallery="quarto-lightbox-gallery-3"><img data-src="images/orlaiv.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
<p><br></p>

<aside><div>
<p><span class="citation" data-cites="wald-dickler2022">(<a href="#/references" role="doc-biblioref" onclick="">Wald-Dickler et al., 2022</a>)</span></p>
</div></aside></section>
<section id="definitions-absorption-bioavailibility" class="slide level2 smaller">
<h2>Definitions: Absorption-Bioavailibility</h2>
<p><br></p>
<ul>
<li><strong>Bioavailability = AUCoral / AUCiv</strong>
<ul>
<li>The relative amount of drug that reaches the greater systemic circulation (i.e.&nbsp;following absorption &amp; first-pass metabolism)</li>
<li>It is the proportion of drug that gets into the plasma vs.&nbsp;the same amount injected IV</li>
</ul></li>
<li><strong>In order to get to the plasma the drug goes through:</strong>
<ul>
<li>Ingestion</li>
<li>Transit through the GI tract</li>
<li>Absorption in small intestinal mucosa</li>
<li>First pass metabolism in small intestinal mucosa and liver</li>
</ul></li>
<li><strong>Bioavailability is used to determine:</strong>
<ul>
<li>The optimal route to achieve the therapeutic concentration</li>
<li>The amount of drug that needs to be given orally</li>
</ul></li>
</ul>
</section>
<section id="oral-absorption-in-the-gi-tract" class="slide level2 smaller">
<h2>Oral absorption in the GI tract</h2>
<p><br></p>
<p><br></p>
<div class="columns">
<div class="column" style="width:20%;">
<p><a href="images/GI-Tract.png" class="lightbox" data-gallery="quarto-lightbox-gallery-4"><img data-src="images/GI-Tract.png" width="300"></a></p>
</div><div class="column" style="width:80%;">
<ul>
<li><strong>Stomach:</strong> Little absorption takes place for most drugs here (thick gastric mucous layer prevents significant drug absorption)</li>
<li><strong>Small intestine:</strong> Transit time 4-6h; 6-7 m long x 2.5cm internal diameter
<ul>
<li>It has a larger surface area (30-35m<sup>2</sup>) than the stomach (~1m<sup>2</sup>), due to:
<ul>
<li>Jejunal plicae circulare (circular infoldings) - increases surface area 1.6x</li>
<li>Epithelial villi + microvilli: increases surface area 80-100x</li>
</ul></li>
</ul></li>
<li><strong>Additional factors aiding absorption:</strong>
<ul>
<li>Peristalsis churns the intestinal contents, ensuring regular contact between drugs &amp; epithelium</li>
<li>pH is 6-7 (weakly acidic) —&gt; determines the ratio of drug molecules that exist in the ionized and unionized state</li>
</ul></li>
</ul>
</div></div>
</section>
<section id="transiting-the-gi-epithelium-into-the-bloodstream" class="slide level2">
<h2>Transiting the GI epithelium into the bloodstream</h2>
<p><br> <br></p>
<table class="caption-top">
<thead>
<tr class="header">
<th><strong>Method of transit</strong></th>
<th><strong>Substrate</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Passive diffusion</strong></td>
<td>&lt;500Da, lipophilic, not ionic</td>
</tr>
<tr class="even">
<td><strong>Facilitated diffusion</strong></td>
<td>&lt;500Da, Lipophobic, ionic drugs</td>
</tr>
<tr class="odd">
<td><strong>Active transport</strong></td>
<td>Ionised drugs</td>
</tr>
<tr class="even">
<td><strong>Pinocytosis</strong></td>
<td>Large molecules</td>
</tr>
</tbody>
</table>
</section>
<section id="passive-diffusion-how-most-antibiotics-are-absorbed" class="slide level2 smaller">
<h2>Passive diffusion: <br>How most antibiotics are absorbed</h2>
<p><br></p>
<p><br></p>
<div class="columns">
<div class="column" style="width:30%;">
<p><a href="images/diffusion.png" class="lightbox" data-gallery="quarto-lightbox-gallery-5"><img data-src="images/diffusion.png" width="3050"></a></p>
</div><div class="column" style="width:70%;">
<ul>
<li><p>Most common way for drugs to cross lipid membranes (esp.&nbsp;if &lt;500 Da &amp; not strongly ionic)</p></li>
<li><p>Lipophilic drugs (e.g.&nbsp;steroids) easily pass through lipid bilayers</p>
<ul>
<li><p>The pKa/b of the weak acid/base determines their rate of uptake:</p>
<ul>
<li><p>pKa = pH at which the acid is 50% ionised (A-) &amp; 50% in the unionised form (AH)</p></li>
<li><p>pKb is the same for bases</p></li>
</ul></li>
<li><p>Ionised drug can’t diffuse through a lipid bilayer</p></li>
<li><p>Unionised drug moves out of the gut lumen, (e.g., as an AH form)</p>
<ul>
<li>Afterwards, ionic (A-) drug molecules combine with free H+ to become AH, which can then move across by passive diffusion</li>
</ul></li>
<li><p>This re-equilibration between ionised &amp; unionised forms continues along the entire length of the gut, with increasing amounts of the drug being gradually absorbed</p></li>
</ul></li>
</ul>
</div></div>
</section>
<section id="a-note-about-absorption-and-ph" class="slide level2 smaller">
<h2>A note about absorption and pH</h2>
<p><br></p>
<div class="columns">
<div class="column" style="width:20%;">
<p><a href="images/stickynote.jpeg.jpg" class="lightbox" data-gallery="quarto-lightbox-gallery-6"><img data-src="images/stickynote.jpeg.jpg" width="800"></a></p>
</div><div class="column" style="width:80%;">
<ul>
<li><p><strong>Drugs are often ‘weak acids’ or ’weak bases,, and so their rate of passive uptake is determined by the ratio of ionised:unionised drug in the gut lumen:</strong></p>
<ul>
<li><p>Acidic drug (A): Can release a H+ ion, going from HA —&gt; A- and H+</p></li>
<li><p>Basic drug (B): Can accept a H+ ion going from B —&gt; BH+ (protonated base)</p></li>
</ul></li>
<li><p><strong>The pKa/b of the weak acid/base determines their rate of uptake:</strong></p>
<ul>
<li><p>pKa = pH at which the acid is 50% ionised (A-) &amp; 50% in the unionised form (AH)</p></li>
<li><p>pKb is the same for bases</p></li>
</ul></li>
<li><p><strong>Ionised drug can’t diffuse through a lipid bilayer</strong></p></li>
<li><p>Unionised drug moves out of the gut lumen, (e.g., as an AH form).</p></li>
<li><p>Afterwards, ionic (A-) drug molecules combine with free H+ to become AH, which can then move across by passive diffusion</p></li>
<li><p>This re-equilibration between ionised &amp; unionised forms continues along the entire length of the gut, with increasing amounts of the drug being gradually absorbed</p></li>
</ul>
</div></div>
</section>
<section id="facilitated-diffusion" class="slide level2 smaller">
<h2>Facilitated diffusion</h2>
<div class="columns">
<div class="column" style="width:50%;">
<p><br> <br> <img data-src="images/diffusion.png"></p>
</div><div class="column" style="width:50%;">
<p><br> <br></p>
<ul>
<li><p>This is how lipophobic drugs cross cell membranes</p></li>
<li><p>This passively happens across an electrochemical concentration gradient.</p></li>
<li><p>Facilitated by solute carrier transporters (SLCs), which are present in the GIT, liver &amp; kidney.</p></li>
<li><p>A note on SLCs:</p>
<ul>
<li>SLCs are a group (&gt;350 types) of transmembrane proteins that facilitate absorption of organic charged molecules up to 500 Daltons.</li>
<li>2 types: <br></li>
</ul></li>
</ul>
<table class="caption-top">
<tbody>
<tr class="odd">
<td>AT Organic Anion Transporter</td>
<td>Carry deprotonated acids A-</td>
</tr>
<tr class="even">
<td>OCT Organic Cation Transporter</td>
<td>Carry protonated bases BH+</td>
</tr>
</tbody>
</table>
</div></div>
</section>
<section id="active-transport" class="slide level2 smaller">
<h2>Active transport</h2>
<div class="columns">
<div class="column" style="width:50%;">
<p><br> <br> <img data-src="images/diffusion.png"></p>
</div><div class="column" style="width:50%;">
<p><br> <br> - <strong>Primary AT:</strong> Mostly efflux of drugs from cells/specific body compartments</p>
<ul>
<li><p>More important in limiting drug uptake</p></li>
<li><p><strong>Secondary AT</strong>: This is how ionised drugs are absorbed</p>
<ul>
<li>Carried out by SLCs (both OATs &amp; OCTs) across pre-existing electrochemical gradients.</li>
<li>Drugs are co-transported e.g.&nbsp;with Na if moving into the intracellular space, or K if moving into the extracellular space</li>
<li>e.g.&nbsp;H+ and beta-lactam antibiotics</li>
</ul></li>
<li><p><strong>Pinocytosis:</strong> This is used to deliver large molecules across tissue barriers (e.g.&nbsp;blood-brain barrier)</p>
<ul>
<li>Endocytosis: the cell membrane invaginates to non-specifically capture molecules present at the cell surface, pinching them off into a vesicle</li>
<li>Exocytosis is the opposite; vesicles are ejected from the cell</li>
</ul></li>
</ul>
</div></div>
</section>
<section id="first-pass-metabolism" class="slide level2 smaller">
<h2>First pass metabolism</h2>
<p><br></p>
<p><br></p>
<div class="columns">
<div class="column" style="width:60%;">
<p><a href="images/Pharmacokinetics%20Principles.png" class="lightbox" data-gallery="quarto-lightbox-gallery-7"><img data-src="images/Pharmacokinetics%20Principles.png"></a></p>
</div><div class="column" style="width:40%;">
<p><br> <br></p>
<ul>
<li>A small amount occurs in the gut epithelia before entering the portal vein. Most occurs in the liver.</li>
<li>As the drug passes through the liver some enters the hepatocytes and is metabolised by the CYP450 enzymes.</li>
</ul>
</div></div>
</section>
<section id="differences-in-iv-vs.-oral-antibiotics" class="slide level2">
<h2>Differences in IV vs.&nbsp;oral antibiotics</h2>
<p><br></p>
<table class="caption-top">
<thead>
<tr class="header">
<th><strong>Oral</strong></th>
<th><strong>IV</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Acid-stable</td>
<td>Acid-labile</td>
</tr>
<tr class="even">
<td>Soluble</td>
<td>Lower solubility</td>
</tr>
<tr class="odd">
<td>Lipid soluble</td>
<td>Lipophobic (hydrophilic)</td>
</tr>
</tbody>
</table>

<aside><div>
<p><span class="citation" data-cites="macgregor1997">(<a href="#/references" role="doc-biblioref" onclick="">MacGregor and Graziani, 1997</a>)</span></p>
</div></aside></section>
<section id="bioavailability-examples" class="slide level2 smaller">
<h2>Bioavailability examples</h2>
<table class="caption-top" style="width:99%;">
<colgroup>
<col style="width: 32%">
<col style="width: 32%">
<col style="width: 32%">
</colgroup>
<tbody>
<tr class="odd">
<td style="text-align: left;"><strong>Mechanism of Action</strong></td>
<td style="text-align: left;"><strong>Antimicrobial</strong></td>
<td style="text-align: center;"><strong>Bioavailability (%)</strong></td>
</tr>
<tr class="even">
<td style="text-align: left;"><strong>Cell wall</strong></td>
<td style="text-align: left;"></td>
<td style="text-align: center;"></td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Penicillin V</td>
<td style="text-align: center;">60</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Amoxicillin</td>
<td style="text-align: center;">80-85</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Amoxicillin-clavulanate</td>
<td style="text-align: center;">80-85/64</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Flucloxacillin</td>
<td style="text-align: center;">60</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Pivmecillinam</td>
<td style="text-align: center;">75</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Cephalexin (1g)</td>
<td style="text-align: center;">90</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Cefuroxime axetil (2g)</td>
<td style="text-align: center;">40</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Cefexime (3g)</td>
<td style="text-align: center;">40</td>
</tr>
<tr class="odd">
<td style="text-align: left;"><strong>Protein synthesis</strong></td>
<td style="text-align: left;"></td>
<td style="text-align: center;"></td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Tetracycline</td>
<td style="text-align: center;">&gt;90</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Doxycycline</td>
<td style="text-align: center;">80-90</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Chloramphenicol</td>
<td style="text-align: center;">85</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Erythromycin</td>
<td style="text-align: center;">20-25</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Clarithromycin</td>
<td style="text-align: center;">55</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Azithromycin</td>
<td style="text-align: center;">37</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Clindamycin</td>
<td style="text-align: center;">90</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Minocycline</td>
<td style="text-align: center;">95</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Linezolid</td>
<td style="text-align: center;">100</td>
</tr>
<tr class="odd">
<td style="text-align: left;"><strong>DNA Synthesis</strong></td>
<td style="text-align: left;"></td>
<td style="text-align: center;"></td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Ciprofloxacin</td>
<td style="text-align: center;">70</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Levofloxacin</td>
<td style="text-align: center;">100</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Moxifloxacin</td>
<td style="text-align: center;">90</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Trimethoprim</td>
<td style="text-align: center;">&gt;90</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Sulfamethoxazole</td>
<td style="text-align: center;">&gt;90</td>
</tr>
<tr class="odd">
<td style="text-align: left;"><strong>Misc.</strong></td>
<td style="text-align: left;"></td>
<td style="text-align: center;"></td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Fosfomycin</td>
<td style="text-align: center;">33-44</td>
</tr>
<tr class="odd">
<td style="text-align: left;"></td>
<td style="text-align: left;">Nitrofurantoin</td>
<td style="text-align: center;">&gt;95</td>
</tr>
<tr class="even">
<td style="text-align: left;"></td>
<td style="text-align: left;">Metronidazole</td>
<td style="text-align: center;">&gt;95</td>
</tr>
</tbody>
</table>

<aside><div>
<p>Source: https://www.medicines.org.uk/</p>
</div></aside></section>
<section id="caveats-to-bioavailibility" class="slide level2">
<h2>Caveats to bioavailibility</h2>
<p><br> <br></p>
<ul>
<li><p>Amoxicillin: Absorption is saturable near 750mg</p>
<ul>
<li>higher doses are unlikely to be absorbed</li>
</ul></li>
<li><p>Cephalexin: Maximum amount absorbed is ~4g/d</p></li>
<li><p>Macrolides: Not well-absorbed, but concentrate intracellularly</p></li>
<li><p>‘UTI drugs’: Fosfomycin, trimethoprim, nitrofurantoin, pivmecillinam:</p>
<ul>
<li>Don’t get great plasma levels, but concentrate in urine preferentially —&gt; still useful for UTI</li>
</ul></li>
</ul>

<aside><div>
<p><span class="citation" data-cites="huttner2020">(<a href="#/references" role="doc-biblioref" onclick="">Huttner et al., 2020</a>)</span></p>
</div></aside></section>
<section id="co-administration-with-food" class="slide level2 smaller">
<h2>Co-administration with food</h2>
<p><br> <br></p>
<table class="caption-top">
<colgroup>
<col style="width: 19%">
<col style="width: 80%">
</colgroup>
<thead>
<tr class="header">
<th><strong>Timing with food</strong></th>
<th><strong>Antibiotic</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>“Empty Stomach” (1h before or 2h after)</td>
<td>Penicillin, <br> Flucloxacillin, <br> Azithromycin, <br> Fosfomycin</td>
</tr>
<tr class="even">
<td>With food</td>
<td>Amoxicillin-clavulanate (start of meal) <br>Erythromycin (just before or with), <br>Metronidazole (during or after), <br>Nitrofurantoin</td>
</tr>
<tr class="odd">
<td>No recommendation</td>
<td>Amoxicillin, <br>Pivmecillinam, <br>Cephalexin, <br>Tetracyclines, <br>Clarithromycin, <br>Clindamycin, <br>Linezolid, <br>Co-trimoxazole, <br>Trimethoprim, <br>Quinolones</td>
</tr>
</tbody>
</table>
</section>
<section id="pharmacology-of-antimicrobials-1" class="slide level2 smaller">
<h2>Pharmacology of antimicrobials</h2>
<div class="cell" data-layout-align="default">
<div class="cell-output-display">
<div>
<p></p><figure class=""><p></p>
<div>
<svg width="960" height="480" viewbox="0.00 0.00 582.13 242.40" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" style="; max-width: none; max-height: none; display: block; margin: auto auto auto auto">
<g id="graph0" class="graph" transform="scale(1 1) rotate(0) translate(4 238.4)">
<title>G</title>
<polygon fill="white" stroke="transparent" points="-4,4 -4,-238.4 578.13,-238.4 578.13,4 -4,4"></polygon>
<g id="clust2" class="cluster">
<title>cluster_1</title>
<polygon fill="lightblue" stroke="lightblue" points="282.3,-67.4 282.3,-226.4 566.13,-226.4 566.13,-67.4 282.3,-67.4"></polygon>
<text text-anchor="middle" x="424.22" y="-209.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacodynamics (PD)</text>
</g>
<g id="clust1" class="cluster">
<title>cluster_0</title>
<polygon fill="lightblue" stroke="lightblue" points="8,-109.4 8,-192.4 262.3,-192.4 262.3,-109.4 8,-109.4"></polygon>
<text text-anchor="middle" x="135.15" y="-175.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacokinetics (PK)</text>
</g>
<!-- start -->
<g id="node1" class="node">
<title>start</title>
<polygon fill="white" stroke="white" points="121.73,-156.4 16.09,-156.4 16.09,-120.4 121.73,-120.4 121.73,-156.4"></polygon>
<text text-anchor="middle" x="68.91" y="-134.2" font-family="Lato,Arial,sans-serif" font-size="14.00">Dosing regimen</text>
</g>
<!-- dosing -->
<g id="node2" class="node">
<title>dosing</title>
<polygon fill="white" stroke="white" points="254.55,-159 157.57,-159 157.57,-117.8 254.55,-117.8 254.55,-159"></polygon>
<text text-anchor="middle" x="206.06" y="-142.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="206.06" y="-125.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> time in serum</text>
<text text-anchor="middle" x="122.23" y="-105" font-family="Lato,Arial,sans-serif" font-size="14.00"> </text>
<text text-anchor="middle" x="122.23" y="-88.2" font-family="Lato,Arial,sans-serif" font-size="14.00"> &nbsp;&nbsp;&nbsp;</text>
<text text-anchor="middle" x="122.23" y="-71.4" font-family="Lato,Arial,sans-serif" font-size="14.00"> &nbsp;</text>
<text text-anchor="middle" x="122.23" y="-54.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Absorption </text>
<text text-anchor="middle" x="122.23" y="-37.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Distribution </text>
<text text-anchor="middle" x="122.23" y="-21" font-family="Lato,Arial,sans-serif" font-size="14.00">Metabolism </text>
<text text-anchor="middle" x="122.23" y="-4.2" font-family="Lato,Arial,sans-serif" font-size="14.00">Elimination</text>
</g>
<!-- start&#45;&gt;dosing -->
<g id="edge1" class="edge">
<title>start-&gt;dosing</title>
<path fill="none" stroke="black" d="M121.78,-138.4C130.14,-138.4 138.84,-138.4 147.33,-138.4"></path>
<polygon fill="black" stroke="black" points="147.54,-141.9 157.54,-138.4 147.54,-134.9 147.54,-141.9"></polygon>
</g>
<!-- tissue -->
<g id="node3" class="node">
<title>tissue</title>
<polygon fill="yellow" stroke="yellow" points="387.26,-193 292.94,-193 292.94,-151.8 387.26,-151.8 387.26,-193"></polygon>
<text text-anchor="middle" x="340.1" y="-176.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="340.1" y="-159.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> time in tissue</text>
</g>
<!-- dosing&#45;&gt;tissue -->
<g id="edge2" class="edge">
<title>dosing-&gt;tissue</title>
<path fill="none" stroke="black" d="M254.36,-150.58C263.58,-152.95 273.34,-155.47 282.83,-157.91"></path>
<polygon fill="black" stroke="black" points="282.02,-161.32 292.58,-160.42 283.76,-154.54 282.02,-161.32"></polygon>
</g>
<!-- infection -->
<g id="node4" class="node">
<title>infection</title>
<polygon fill="yellow" stroke="yellow" points="389.69,-133.8 290.51,-133.8 290.51,-75 389.69,-75 389.69,-133.8"></polygon>
<text text-anchor="middle" x="340.1" y="-117" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="340.1" y="-100.2" font-family="Lato,Arial,sans-serif" font-size="14.00"> time at site of </text>
<text text-anchor="middle" x="340.1" y="-83.4" font-family="Lato,Arial,sans-serif" font-size="14.00"> infection</text>
</g>
<!-- dosing&#45;&gt;infection -->
<g id="edge3" class="edge">
<title>dosing-&gt;infection</title>
<path fill="none" stroke="black" d="M254.36,-126.22C262.85,-124.03 271.8,-121.73 280.56,-119.47"></path>
<polygon fill="black" stroke="black" points="281.54,-122.84 290.35,-116.95 279.8,-116.06 281.54,-122.84"></polygon>
</g>
<!-- PD1 -->
<g id="node5" class="node">
<title>PD1</title>
<polygon fill="white" stroke="white" points="558.25,-193 425.77,-193 425.77,-151.8 558.25,-151.8 558.25,-193"></polygon>
<text text-anchor="middle" x="492.01" y="-176.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacological or &nbsp;</text>
<text text-anchor="middle" x="492.01" y="-159.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> toxicological effect</text>
</g>
<!-- tissue&#45;&gt;PD1 -->
<g id="edge4" class="edge">
<title>tissue-&gt;PD1</title>
<path fill="none" stroke="black" d="M387.3,-172.4C396.3,-172.4 405.96,-172.4 415.62,-172.4"></path>
<polygon fill="black" stroke="black" points="415.67,-175.9 425.67,-172.4 415.67,-168.9 415.67,-175.9"></polygon>
</g>
<!-- PD2 -->
<g id="node6" class="node">
<title>PD2</title>
<polygon fill="white" stroke="white" points="556.52,-125 427.51,-125 427.51,-83.8 556.52,-83.8 556.52,-125"></polygon>
<text text-anchor="middle" x="492.01" y="-108.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Antimicrobal effect </text>
<text text-anchor="middle" x="492.01" y="-91.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> vs. time</text>
</g>
<!-- infection&#45;&gt;PD2 -->
<g id="edge5" class="edge">
<title>infection-&gt;PD2</title>
<path fill="none" stroke="black" d="M389.77,-104.4C398.56,-104.4 407.9,-104.4 417.22,-104.4"></path>
<polygon fill="black" stroke="black" points="417.3,-107.9 427.3,-104.4 417.3,-100.9 417.3,-107.9"></polygon>
</g>
</g>
</svg>
</div>
<p></p></figure><p></p>
</div>
</div>
</div>
</section>
<section id="volume-of-distribution" class="slide level2">
<h2>Volume of distribution</h2>
<p><br></p>
<div class="columns">
<div class="column" style="width:30%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/beaker.png" class="lightbox" data-gallery="quarto-lightbox-gallery-8"><img data-src="images/beaker.png" class="quarto-figure quarto-figure-center" width="300"></a></p>
</figure>
</div>
</div><div class="column" style="width:70%;">
<ul>
<li><p>The volume which appears to hold the drug if it was present in the body at the same concentration found in plasma</p>
<ul>
<li>It is estimated, not directly measured</li>
</ul></li>
<li><p>Reported in litres (L) or litres per kilogram (L/kg)</p></li>
<li><p>Average plasma volume in adults is approximately 3L</p></li>
</ul>
<p><span class="math display">\[
Vd=Dose/Cp
\]</span></p>
</div></div>

<aside><div>
<p>Vd= volume of distribution, Dose=drug dose, Cp= drug concentration in plasma</p>
</div></aside></section>
<section id="visualizing-the-vd" class="slide level2 smaller">
<h2>Visualizing the Vd</h2>
<div class="columns">
<div class="column" style="width:50%;">
<p><br> <br></p>
<p><a href="images/vd.png" class="lightbox" data-gallery="quarto-lightbox-gallery-9"><img data-src="images/vd.png"></a></p>
</div><div class="column" style="width:50%;">
<p><br> <br> <img data-src="images/bodycomp.png" width="183"></p>
</div></div>

<aside><div>
<p><a href="https://idiots.notion.site/ID-IOTS-Episode-Notes-cf9b043fbb5a41309e15270f6079abf5" class="uri">https://idiots.notion.site/ID-IOTS-Episode-Notes-cf9b043fbb5a41309e15270f6079abf5</a></p>
</div></aside></section>
<section id="clinical-importance-of-vd" class="slide level2 smaller">
<h2>Clinical importance of Vd</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/vd_clinical.png" class="lightbox" data-gallery="quarto-lightbox-gallery-10"><img data-src="images/vd_clinical.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
<p>Provides information on how much antibiotic is distributed in tissues vs.&nbsp;plasma → important for antibiotic selection</p>
<p>e.g., doxycycline, tigecycline do not achieve peak concentrations in bloodstream that surpass the MIC of many pathogens</p>
</section>
<section id="factors-affecting-vd-drug-characteristics" class="slide level2 smaller">
<h2>Factors affecting Vd: Drug characteristics</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/hydrophilic.png" class="lightbox" data-gallery="quarto-lightbox-gallery-11"><img data-src="images/hydrophilic.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
<ul>
<li><p>Volume of distribution is affected by the physicochemical properties of the drug</p></li>
<li><p>Factors that favour low Vd: high water solubility, high protein binding, decreased tissue binding → converse is also true</p></li>
</ul>
</section>
<section id="factors-affecting-volume-of-distribution" class="slide level2">
<h2>Factors affecting volume of distribution</h2>
<p><br></p>
<ul>
<li><p>Ease of crossing phospholipid bilayers</p></li>
<li><p>Interactions with lipid tissue (lipophilic = more distribution into fat)</p></li>
<li><p>Interactions with protein</p></li>
</ul>
</section>
<section id="examples-of-how-drug-factors-affect-vd" class="slide level2 smaller">
<h2>Examples of how drug factors affect Vd</h2>
<p><br></p>
<p><strong>Lipophilic vs.&nbsp;hydrophilic</strong></p>
<ul>
<li><p>More lipophilic antibiotics diffuse faster out of plasma into tissue; they favour distribution to lipid-rich tissues</p></li>
<li><p>If the drug has a net negative charge, it can still leave capillaries through endothelial fenestrations but further tissue penetration depends on:</p>
<ul>
<li><p>Interstitial fluid pH</p></li>
<li><p>Drug pKa</p></li>
<li><p>Presence of OAT/OCT carriers</p></li>
</ul></li>
</ul>
<p><strong>Plasma protein binding</strong></p>
<p>There are several plasma protein that bind drugs with weak electrical polar bonds allowing</p>
<ul>
<li><p>Storage/transport of “bound” drug</p></li>
<li><p>Quick release of the drug to become “free drug”</p></li>
<li><p>Only free drug distributes out of plasma and has pharmacological effect</p></li>
</ul>
</section>
<section id="factors-affecting-volume-of-distribution-cont." class="slide level2">
<h2>Factors affecting volume of distribution, cont.</h2>
<p><br><br></p>
<ul>
<li><p><strong>Tissue protein binding (e.g., muscle)</strong></p>
<ul>
<li><p>This ‘drains’ the drug from plasma</p></li>
<li><p>This will in turn reduce amount of plasma free drug</p></li>
</ul></li>
<li><p><strong>Tissue binding sites</strong></p>
<ul>
<li>Antibiotic example?</li>
</ul></li>
</ul>
</section>
<section id="factors-affecting-vd-vascular-perfusion" class="slide level2" data-background-image="images/capillary.png" data-background-opacity="0.1">
<h2>Factors affecting Vd: Vascular perfusion</h2>
<p><br> <br></p>
<ul>
<li><p><strong>Drugs diffuse from capillary beds—&gt; interstitial —&gt; intracellular space</strong></p></li>
<li><p><strong>More vascular tissue (e.g., heart, lung, kidney) have greater drug delivery vs.&nbsp;skin, bone, fat</strong></p></li>
<li><p><strong>Capillary leakiness:</strong></p>
<ul>
<li><p>Some capillary bed epithelial cells are fenestrated by 60-80nm diameter pores (e.g.&nbsp;intestinal, endocrine, pancreatic and kidney).</p></li>
<li><p>In others endothelial cells are separated by slit junctions or large intercellular gaps to allow large movements of molecular material (Liver, bone marrow, lymph nodes, spleen).</p></li>
<li><p>These ‘leak’ points facilitate access to the interstitial fluid.</p></li>
</ul></li>
</ul>
</section>
<section id="sepsis-alters-the-vd-of-antibiotics" class="slide level2 smaller">
<h2>Sepsis alters the Vd of antibiotics</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/vd3.png" class="lightbox" data-gallery="quarto-lightbox-gallery-12"><img data-src="images/vd3.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
<p>Release of inflammatory&nbsp;mediators causes damage to the vascular endothelium,&nbsp;resulting in expansion of extravascular space&nbsp;(increased volume of distribution)</p>
</section>
<section id="factors-affecting-vd-body-size-and-chronic-diseases" class="slide level2 smaller">
<h2>Factors affecting Vd: <br>Body size and chronic diseases</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/vd2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-13"><img data-src="images/vd2.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
</section>
<section id="anatomically-privileged-sites-1" class="slide level2 smaller">
<h2>Anatomically privileged sites-1</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/antomic_priv1.png" class="lightbox" data-gallery="quarto-lightbox-gallery-14"><img data-src="images/antomic_priv1.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
</section>
<section id="anatomically-privileged-sites-2" class="slide level2 smaller">
<h2>Anatomically privileged sites-2</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/anatomic_privlidge2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-15"><img data-src="images/anatomic_privlidge2.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
</section>
<section id="ventilator-associated-pneumonia" class="slide level2 smaller">
<h2>Ventilator-associated pneumonia</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/meropeneme_elf.png" class="lightbox" data-gallery="quarto-lightbox-gallery-16"><img data-src="images/meropeneme_elf.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="lodise2011">(<a href="#/references" role="doc-biblioref" onclick="">Lodise et al., 2011</a>)</span></p>
</div></aside></section>
<section id="how-is-the-drug-metabolised-concentrated-or-excreted" class="slide level2 smaller">
<h2>How is the drug metabolised, <br> concentrated, or excreted?</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/excreted.png" class="lightbox" data-gallery="quarto-lightbox-gallery-17"><img data-src="images/excreted.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
</section>
<section id="which-antibiotics-are-excreted-in-urine" class="slide level2">
<h2>Which antibiotics are excreted in urine?</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/urine.png" class="lightbox" data-gallery="quarto-lightbox-gallery-18"><img data-src="images/urine.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="gilbert2006">(<a href="#/references" role="doc-biblioref" onclick="">Gilbert, 2006</a>)</span></p>
</div></aside></section>
<section id="antibiotic-elimination" class="slide level2">
<h2>Antibiotic Elimination</h2>
<p><br> <br></p>
<ul>
<li><p>Definition: Processes that irreversibly remove a drug from the body</p></li>
<li><p>The “drug out” part of pharmacokinetics</p></li>
<li><p>Metabolism of the drug determines how the drug is excreted</p>
<ul>
<li>Not all drugs are metabolised before excretion (excreted unchanged)</li>
</ul></li>
<li><p>Elimination starts as soon as drug first enters the liver; it is an ongoing process that does not ‘wait’ until the drug has finished distributing equally throughout the body</p></li>
</ul>
</section>
<section id="metabolism" class="slide level2 smaller">
<h2>Metabolism</h2>
<p><br></p>
<ul>
<li><p>Definition: Chemical conversion of a drug into a form amenable to excretion.</p></li>
<li><p>This is achieved through 2 main ways: Phase I &amp; II reactions</p></li>
</ul>
<table class="caption-top" style="width:99%;">
<colgroup>
<col style="width: 13%">
<col style="width: 47%">
<col style="width: 38%">
</colgroup>
<thead>
<tr class="header">
<th><strong>Phase I</strong></th>
<th><strong>Chemical reactions</strong></th>
<th><strong>Effect</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td></td>
<td>Oxidation/Reduction</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>Hydrolysis</td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>Introduce/unmask polar groups on drug: (-OH or -NH2)</td>
<td></td>
</tr>
<tr class="even">
<td><strong>Phase II</strong></td>
<td>Conjugation</td>
<td><p>Addition of polar groups to drug:</p>
<ul>
<li><p>Glucuronate (glucuronidation)</p></li>
<li><p>Glutathione (Glutathione conjugation)</p></li>
<li><p>Glycine (Glycine conjugation)</p></li>
<li><p>Sulphate (Sulphation)</p></li>
<li><p>Acetyl (Acetylation)</p></li>
<li><p>Methyl (Methylation)</p></li>
</ul></td>
</tr>
</tbody>
</table>
</section>
<section id="metabolism-1" class="slide level2">
<h2>Metabolism</h2>
<p><br><br></p>
<ul>
<li><p>These reactions enhance the drug’s ionic charge, which makes them easier to excrete</p></li>
<li><p>This is essential for lipophilic drugs, which will otherwise simply diffuse back across the renal cell membranes, then back into the plasma. These reactions are responsible for the “First-Pass metabolism</p></li>
<li><p>The main sites of metabolism are liver, kidneys &amp; lung, but these enzymes are present at various levels in most tissues</p></li>
<li><p>Not all drugs undergo both phases: e.g., some drugs undergo Phase II directly, depending if they already possess -OH, -NH or COOH groups</p></li>
</ul>
</section>
<section id="phase-i-cytochrome-p450-enzymes" class="slide level2 smaller">
<h2>Phase I: Cytochrome P450 Enzymes</h2>
<p><br> <br></p>
<ul>
<li><p>Definition: A large family of &gt;50 hepatic enzymes that primarily oxidise drugs</p></li>
<li><p>Site: mostly on hepatocyte endoplasmic reticulum</p></li>
<li><p>They are responsible for most Phase I metabolism</p></li>
<li><p>Main CYPs (~90% drug metabolism) are: 3A4, 2D6, then 1A2, 2C9, &amp; 2C19. 3A4 metabolises 50% of drugs</p></li>
<li><p>Nomenclature:</p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/cyp.png" class="lightbox" data-gallery="quarto-lightbox-gallery-19"><img data-src="images/cyp.png" class="quarto-figure quarto-figure-center" width="600"></a></p>
</figure>
</div></li>
</ul>
</section>
<section id="cyp-speed-vs-generalism" class="slide level2">
<h2>CYP Speed vs Generalism</h2>
<p><br> <br></p>
<ul>
<li><p>CYP enzymes are “generalists”</p>
<ul>
<li>Each isoenzyme has a wide array of drug ‘targets’ ( drugs are metabolised by several different enzymes)</li>
</ul></li>
<li><p>This “generalisability” comes at the expense of speed; compared to one specialised enzyme that could break down one specific molecule, CYP enzymes are much slower</p></li>
<li><p>This versatility contributes to the variation in elimination half-lives seen for drugs</p></li>
</ul>
</section>
<section id="factors-affecting-cyp-enzyme-activity" class="slide level2">
<h2>Factors Affecting CYP enzyme activity</h2>
<p><br> <br></p>
<table class="caption-top">
<colgroup>
<col style="width: 11%">
<col style="width: 88%">
</colgroup>
<thead>
<tr class="header">
<th><strong>Factor</strong></th>
<th><strong>Explanation</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Age</strong></td>
<td>Declines with age</td>
</tr>
<tr class="even">
<td><strong>Sex</strong></td>
<td>Males have larger livers —&gt; more rapid metabolism of drugs</td>
</tr>
<tr class="odd">
<td><strong>Genetics</strong></td>
<td>CYP isoenzymes exhibit high rates of genetic polymorphism, which can affect the efficiency with which the individual can process the enzyme’s drug targets.</td>
</tr>
<tr class="even">
<td><strong>Cardiac output</strong></td>
<td>Less cardiac output —&gt; less drug delivered to the liver per minute —&gt; slower rate of metabolism.</td>
</tr>
<tr class="odd">
<td><strong>Drugs</strong></td>
<td>See below</td>
</tr>
</tbody>
</table>
</section>
<section id="cyp-enzyme-inductioninhibition" class="slide level2 smaller">
<h2>CYP Enzyme Induction/Inhibition</h2>
<p><br> <br></p>
<ul>
<li><p><strong>Certain drugs can affect expression of CYPs through:</strong></p>
<ul>
<li><p>Induction (Increased transcription/translation, or slower degradation)</p></li>
<li><p>Inhibition (Increased degradation)</p></li>
<li><p>This will lead to increased/decreased metabolism of the CYP enzyme’s substrate drugs, respectively</p></li>
</ul></li>
<li><p><strong>CYP Enzyme inducers</strong></p>
<ul>
<li><p>200 drugs known to be inducers</p></li>
<li><p>Induction takes 1-2 weeks on average</p>
<ul>
<li>NB: Rifampicin induction starts within 24h, and has full induction (of CYP3A4) at 72h</li>
<li>E.g. PC BRAS drugs: <strong>P</strong>henytoin, <strong>C</strong>arbamazepine, <strong>B</strong>arbiturates, <strong>R</strong>ifampicin, <strong>A</strong>lcohol (Chronic use), <strong>S</strong>ulfonylureas</li>
</ul></li>
</ul></li>
<li><p><strong>CYP Enzyme inhibitors</strong></p>
<ul>
<li><p>These tend to increase the plasma level of substrate drugs due to decreased degradation by CYPs</p></li>
<li><p>Occurs much more quickly (~1-3 days)</p></li>
<li><p>NB: Clinically important inhibitors ‘missed’ by this mnemonic include Amiodarone, SSRIs &amp; Grapefruit juice</p></li>
</ul></li>
</ul>
</section>
<section id="excretion" class="slide level2 smaller">
<h2>Excretion</h2>
<p><br> <br></p>
<ul>
<li><p><strong>Drug metabolism has 3 outcomes:</strong></p>
<ul>
<li><p>Drug is metabolised to inactive metabolite</p></li>
<li><p>Drug is metabolised to metabolite with therapeutic activity (e.g.&nbsp;Metronidazole’s metabolite is still active)</p></li>
<li><p>‘Prodrug’ is metabolised to active form (e.g.&nbsp;Codeine to Morphine)</p></li>
</ul></li>
<li><p>Regardless of what outcome occurs, the drug is ionised, making excretion easier</p></li>
<li><p>Main sites of excretion:</p>
<ul>
<li><p>Kidney (main site; covered below)</p></li>
<li><p>GI tract</p></li>
<li><p>Lung (in breath)</p></li>
<li><p>Skin (Sweat, tears)</p></li>
</ul></li>
</ul>
</section>
<section id="renal-excretion" class="slide level2 smaller">
<h2>Renal excretion</h2>
<p><br> <br></p>
<p><strong>Occurs in 3 stages</strong></p>
<ul>
<li><p><strong>Glomerular filtration</strong></p>
<ul>
<li><p>~20% Renal blood flow serves the glomerulus</p></li>
<li><p>Free drug &amp; metabolites passively diffuse across into Bowman’s capsule.</p></li>
</ul></li>
<li><p><strong>Proximal tubular secretion</strong></p>
<ul>
<li><p>~80% Renal blood flow serves the rest of the nephron</p></li>
<li><p>OAT and OACTs actively transport polar molecules into urine</p></li>
</ul></li>
<li><p><strong>Distal tubular reabsorption</strong></p>
<ul>
<li><p>As water is reabsorbed along the tubule, urine drug/metabolite concentration increases</p></li>
<li><p>Lipophilic molecules will then diffuse down their concentration gradient, across the uroepithelium back into the plasma</p></li>
</ul></li>
</ul>
</section>
<section id="clearance-key-pharmacokinetic-parameter" class="slide level2">
<h2>Clearance: Key pharmacokinetic parameter</h2>
<p><br></p>
<ul>
<li><p><strong>Drug elimination from the body</strong></p>
<ul>
<li><p>Described by volume of blood removed of drug unit per time</p></li>
<li><p>For example: If drug A as a clearance of 39 L/h or 650 ml/min, then every minute, the equivalent of 0.65L of the Vd can be “cleansed” of drug A</p></li>
<li><p>Unit of measure mL/min or L/hr</p></li>
<li><p>Clearance is affected by</p>
<ul>
<li>Patient disease, organ function, genetic, interactions with other drugs</li>
</ul></li>
</ul></li>
</ul>

<aside><div>
<p>Changes in clearance between different patients: <em>inter</em> patient variability</p>
<p>Changes in clearance over time in the same patient: <em>intra</em> patient variability</p>
</div></aside></section>
<section id="example-meropenem-in-septic-patients" class="slide level2 smaller">
<h2>Example: Meropenem in septic patients</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/meropenem_sepsis.png" class="lightbox" data-gallery="quarto-lightbox-gallery-20"><img data-src="images/meropenem_sepsis.png" class="quarto-figure quarto-figure-center" width="400"></a></p>
</figure>
</div>

<aside><div>
<p>Typical meropenem Vd 15-20 L with clearance of 10-13 L/h</p>
<p><span class="citation" data-cites="kothekar2020">(<a href="#/references" role="doc-biblioref" onclick="">Kothekar et al., 2020</a>)</span></p>
</div></aside></section>
<section id="integrating-volume-of-distribution-and-clearance" class="slide level2">
<h2>Integrating Volume of distribution and clearance</h2>
<p><br></p>
<ul>
<li><p><strong>Vd and CL are physiologically-based</strong></p>
<ul>
<li><p>A change in fluid status or distribution can affect Vd</p></li>
<li><p>A change in kidney of liver function can affect drug CL</p></li>
</ul></li>
<li><p><strong>However, these parameters do not directly interaction with each other</strong></p>
<ul>
<li>A change in Vd does not change clearance and vice versa</li>
</ul></li>
</ul>
</section>
<section id="why-is-this-distinction-important" class="slide level2">
<h2>Why is this distinction important?</h2>
<p><br></p>
<ul>
<li><p><strong>Vd is useful fo calculating the <u>loading dose</u> of a drug</strong></p></li>
<li><p><strong>CL is useful for calculating the <u>maintenance dose</u> of a drug</strong></p>
<ul>
<li>CL is not used to calculate the loading dose (or initial dose) because it is not affected by the volume of distribution</li>
</ul></li>
</ul>
</section>
<section id="key-pharmacokinetic-parameter-elimination-rate" class="slide level2">
<h2>Key pharmacokinetic parameter: Elimination rate</h2>
<p><br></p>
<p><br></p>
<div class="columns">
<div class="column" style="width:50%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/clearance.png" class="lightbox" data-gallery="quarto-lightbox-gallery-21"><img data-src="images/clearance.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
</div><div class="column" style="width:50%;">
<ul>
<li><p>What is <em>k</em><sub>el</sub>?</p>
<ul>
<li>Rate of drug removed per unit of time</li>
<li>Calculated parameter: Unit of measure: reciprocal time (hr<sup>-1</sup>)</li>
</ul></li>
</ul>
</div></div>
<p><span class="math display">\[
Kel =CL/Vd
\]</span></p>
</section>
<section id="key-pharmacokinetic-parameter-half-life" class="slide level2">
<h2>Key pharmacokinetic parameter: <br> Half life</h2>
<p><br></p>
<ul>
<li><p>Time it takes for plasma concentration or amount in body to be reduced by 50%</p></li>
<li><p>It is a calculated parameter</p>
<ul>
<li><p>Function of clearance and volume of distribution</p>
<ul>
<li>Unit of measure = time (hours, minutes, days)</li>
</ul></li>
</ul></li>
</ul>
<p><span class="math display">\[
t_{½}= \frac{0.693}{k_{el}}
\]</span> <span class="math display">\[
t_{½}= \frac{0.693\ast Vd}{Cl}
\]</span></p>
</section>
<section id="half-life-examples" class="slide level2">
<h2>Half-life examples</h2>
<p><br></p>
<p><br></p>
<table class="caption-top">
<thead>
<tr class="header">
<th><strong>Drug</strong></th>
<th><strong>Half life (h)</strong></th>
<th><strong>Dosing regimen</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Amoxicillin</strong></td>
<td>1</td>
<td>8-hourly</td>
</tr>
<tr class="even">
<td><strong>Doxycycline</strong></td>
<td>12</td>
<td>Daily</td>
</tr>
</tbody>
</table>
<p><br></p>
<p><br></p>
<p>Most of a drug will be eliminated without repeat dosing by 5-6 half-lives</p>
</section>
<section id="beta-lactam-examples" class="slide level2 smaller">
<h2>Beta-lactam examples</h2>
<p><br></p>
<table class="caption-top" style="width:98%;">
<colgroup>
<col style="width: 10%">
<col style="width: 37%">
<col style="width: 17%">
<col style="width: 14%">
<col style="width: 10%">
<col style="width: 8%">
</colgroup>
<thead>
<tr class="header">
<th><strong>Antimicrobial</strong></th>
<th><strong>Metabolism</strong></th>
<th><strong>Excretion</strong></th>
<th><strong>Vd (L); Bold = from DrugBank</strong></th>
<th><strong>Clearance (ml/min)</strong></th>
<th><strong>Half life (h)</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Penicillin G</strong></td>
<td>16-30% Penicilloic acid; Small amounts to 6-aminopenicillanic acid &amp; active metabolites</td>
<td>Renal: Most Hepatic: some Faecal: some</td>
<td>35.4</td>
<td>560</td>
<td>0.4 - 0.9</td>
</tr>
<tr class="even">
<td><strong>Penicillin V</strong></td>
<td>35-70% Penicilloic acid; Small amounts to 6-aminopenicillanic acid &amp; active metabolites</td>
<td>Renal: 25</td>
<td>35.4</td>
<td>N/A</td>
<td>0.5</td>
</tr>
<tr class="odd">
<td><strong>Amoxicillin</strong></td>
<td>7 metabolites (M1-7)</td>
<td>Renal: 74</td>
<td>27.7</td>
<td>355</td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>Nafcillin</strong></td>
<td>None</td>
<td>Hepatic &lt;30</td>
<td>28</td>
<td>N/A</td>
<td>0.5 - 1</td>
</tr>
<tr class="odd">
<td><strong>Flucloxacillin</strong></td>
<td></td>
<td>Hepatic: mostly</td>
<td>13</td>
<td></td>
<td>0.75 - 1</td>
</tr>
<tr class="even">
<td><strong>Pivmecillinam</strong></td>
<td></td>
<td>Renal: 50% / 6h Hepatic: partially</td>
<td>14 - 28</td>
<td></td>
<td>1.2</td>
</tr>
<tr class="odd">
<td><strong>Piperacillin</strong></td>
<td></td>
<td>Renal: Most Hepatic: some</td>
<td>14 - 21</td>
<td>32 - 41</td>
<td>0.6 - 1.2</td>
</tr>
<tr class="even">
<td><strong>Tazobactam</strong></td>
<td>M1 metabolite</td>
<td>Renal: 80% / 20% M1</td>
<td>18.2</td>
<td>48 - 84</td>
<td>0.7 - 1.2</td>
</tr>
<tr class="odd">
<td><strong>Cephalexin</strong></td>
<td>None</td>
<td>Renal: 99%/24h</td>
<td>5.2 - 5.8</td>
<td></td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>Cefazolin</strong></td>
<td>None</td>
<td>Renal: 80%/24h</td>
<td>9 - 15</td>
<td></td>
<td>1.9</td>
</tr>
<tr class="odd">
<td><strong>Cefuroxime axetil</strong></td>
<td>None; Axetil to Acetic acid + Aldehyde</td>
<td>Mostly (unchanged)</td>
<td>50</td>
<td>125 - 148</td>
<td>1.3</td>
</tr>
<tr class="even">
<td><strong>Ceftriaxone</strong></td>
<td></td>
<td>Renal: 33 - 67 Hepatic: 33 - 67</td>
<td>5.8 - 13.5</td>
<td></td>
<td>5.8-8.7</td>
</tr>
<tr class="odd">
<td><strong>Ceftazidime</strong></td>
<td></td>
<td>~85%/24h</td>
<td>15 - 20</td>
<td>115</td>
<td>1.5 - 2.8</td>
</tr>
<tr class="even">
<td><strong>Cefepime</strong></td>
<td>&lt;1%</td>
<td>~85%</td>
<td>18</td>
<td>120</td>
<td>2</td>
</tr>
<tr class="odd">
<td><strong>Ceftolozane</strong></td>
<td>Nil</td>
<td>~100%</td>
<td>13.5</td>
<td>57 - 110</td>
<td>2.8 - 3.1</td>
</tr>
<tr class="even">
<td><strong>Ceftaroline fosamil</strong></td>
<td>By plasma phosphatase to active ceftaroline</td>
<td>Renal: Mostly (unchanged) Faecal: &lt;6%</td>
<td>20</td>
<td></td>
<td>1.6</td>
</tr>
<tr class="odd">
<td><strong>Ertapenem</strong></td>
<td>50% to inactive metabolite</td>
<td>Renal: 80% Faecal: 10%</td>
<td>8.4</td>
<td>28</td>
<td>4</td>
</tr>
<tr class="even">
<td><strong>Meropenem</strong></td>
<td>Negligible</td>
<td>70%</td>
<td>17.5 - 24.5</td>
<td></td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>Aztreonam</strong></td>
<td>~11% to inactive compound</td>
<td>100%/12h</td>
<td>12.6</td>
<td>91</td>
<td>~1.7</td>
</tr>
</tbody>
</table>
</section>
<section id="non-beta-lactam-antibiotics" class="slide level2 smaller">
<h2>Non beta-lactam antibiotics</h2>
<p><br></p>
<table class="caption-top" style="width:98%;">
<colgroup>
<col style="width: 10%">
<col style="width: 8%">
<col style="width: 20%">
<col style="width: 22%">
<col style="width: 15%">
<col style="width: 10%">
<col style="width: 8%">
</colgroup>
<thead>
<tr class="header">
<th><strong>Target</strong></th>
<th><strong>Antimicrobial</strong></th>
<th><strong>Metabolism</strong></th>
<th><strong>Elimination</strong></th>
<th><strong>Vd (L); Bold = from DrugBank</strong></th>
<th><strong>Clearance (ml/min)</strong></th>
<th><strong>Half life (h)</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Cell wall</strong></td>
<td>Vancomycin</td>
<td>Negligible</td>
<td>75%</td>
<td>28 - 70</td>
<td>68</td>
<td>6</td>
</tr>
<tr class="even">
<td></td>
<td>Dalbavancin</td>
<td>&lt;25% to less active metabolites</td>
<td>Renal: 33% unchanged; 12% metabolites Faecal: 20%</td>
<td>14</td>
<td>0.9</td>
<td>346</td>
</tr>
<tr class="odd">
<td><strong>Protein Synthesis</strong></td>
<td>Gentamicin</td>
<td>Negligible</td>
<td>70%</td>
<td>20 - 26</td>
<td>as per CrCl (~100)</td>
<td>1.25</td>
</tr>
<tr class="even">
<td></td>
<td>Amikacin</td>
<td>Negligible</td>
<td>94%</td>
<td>24</td>
<td>as per CrCl (~100)</td>
<td>2</td>
</tr>
<tr class="odd">
<td></td>
<td>Doxycycline</td>
<td></td>
<td>Renal: 40% Hepatic: significant</td>
<td>52.5</td>
<td>58</td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>Tigecycline</td>
<td>10%</td>
<td></td>
<td>490 - 630</td>
<td></td>
<td>27-43</td>
</tr>
<tr class="odd">
<td></td>
<td>Clarithromycin</td>
<td>predominantly by 3A4</td>
<td>30%</td>
<td>191 - 306</td>
<td></td>
<td>3-4</td>
</tr>
<tr class="even">
<td></td>
<td>Azithromycin</td>
<td></td>
<td>Renal: 6% Hepatic: significant</td>
<td>2177</td>
<td>630</td>
<td>68</td>
</tr>
<tr class="odd">
<td></td>
<td>Clindamycin</td>
<td>to 2 inactive metabolites, by 3A4 and 3A5</td>
<td>Renal: 10% Faeces: 3.6%</td>
<td>43 - 74</td>
<td>250</td>
<td>3</td>
</tr>
<tr class="even">
<td></td>
<td>Linezolid</td>
<td>to 2 inactive metabolites, unclear mechanism</td>
<td>Renal: 30% unchanged, 50% metabolites Faeces: 6%</td>
<td>40 - 50</td>
<td>100-200</td>
<td>5-7</td>
</tr>
<tr class="odd">
<td><strong>DNA Synthesis</strong></td>
<td>Ciprofloxacin</td>
<td>~20% to 4 metabolites</td>
<td>Renal: 45% Faeces: 62%</td>
<td>140 - 213</td>
<td>350 - 630</td>
<td>4</td>
</tr>
<tr class="even">
<td></td>
<td>Levofloxacin</td>
<td>&lt;5% as 2 metabolites</td>
<td>Renal: 87% Faeces: 4%</td>
<td>89 - 112</td>
<td>143 - 227</td>
<td>6 - 8</td>
</tr>
<tr class="odd">
<td></td>
<td>Moxifloxacin</td>
<td>50%; Phase I conjugation/ sulphation</td>
<td>Renal: 20% Faeces: 25%</td>
<td>119 - 189</td>
<td>200</td>
<td>11.5 - 15.6</td>
</tr>
<tr class="even">
<td></td>
<td>Trimethoprim</td>
<td>90% to 2 inactive metabolites; by 2C9/3A4</td>
<td>Renal: ~55% Hepatic: ~15%</td>
<td>25.2</td>
<td>50 - 90</td>
<td>8 - 10</td>
</tr>
<tr class="odd">
<td></td>
<td>Sulfamethoxazole</td>
<td>To inactive metabolites; CYP2C9;</td>
<td>Renal: 85%</td>
<td>13</td>
<td>20</td>
<td>10</td>
</tr>
<tr class="even">
<td><strong>Other</strong></td>
<td>Daptomycin</td>
<td>Some to inactive metabolites</td>
<td>Renal: 80% Faecal: 6%</td>
<td>7</td>
<td>~9.8</td>
<td>7.5 - 9</td>
</tr>
<tr class="odd">
<td></td>
<td>Colistin</td>
<td>Tissue metabolism: 20%</td>
<td>Renal: 80%</td>
<td>9 - 12</td>
<td></td>
<td>5</td>
</tr>
<tr class="even">
<td></td>
<td>Fosfomycin</td>
<td>Nil</td>
<td>Renal: 100%</td>
<td>21 - 30</td>
<td>283</td>
<td>5.7</td>
</tr>
<tr class="odd">
<td></td>
<td>Nitrofurantoin</td>
<td>~1.3% to Aminofurantoin</td>
<td>Renal: 90%</td>
<td>42</td>
<td>278 - 323</td>
<td>~0.76</td>
</tr>
<tr class="even">
<td></td>
<td>Metronidazole</td>
<td>To 5 metabolites; 1 is active also</td>
<td>Renal: ~70% Faeces: ~10%</td>
<td>36 - 77</td>
<td>10</td>
<td>6 - 10</td>
</tr>
</tbody>
</table>
</section>
<section id="key-pharmacokinetic-parameter-area-under-the-curve-auc" class="slide level2 smaller">
<h2>Key pharmacokinetic parameter: <br>Area under the curve (AUC)</h2>
<p><br></p>
<div class="columns">
<div class="column" style="width:50%;">
<p><a href="images/AUC.png" class="lightbox" data-gallery="quarto-lightbox-gallery-22"><img data-src="images/AUC.png"></a></p>
</div><div class="column" style="width:50%;">
<ul>
<li><p>Total drug exposure over time, expressed as mg∙h/L</p></li>
<li><p>Dependent on the dose administered and rate of elimination</p></li>
<li><p>Calculated by adding up or integrating the amounts of drug eliminated in discreet time intervals, from zero (time of the administration of the drug) to a defined time-e.g., 24 hours</p></li>
<li><p>Can simplistically be interpreted as average dur exposure over a dosing interval:</p>
<ul>
<li>e.g., an AUC<sub>0-24h</sub> of 48 mg∙h/L for a dosing regimen administered every 24 hours would represent an average concentration over the 24 hour dosing interval of 2 mg/L (48 mg∙h/L divided by 24 hr=2 mg∙L average over 24 hours).</li>
</ul></li>
</ul>
</div></div>
</section>
<section id="renal-impairment" class="slide level2">
<h2>Renal impairment</h2>
<p><br> <br></p>
<ul>
<li>Well established dosing adjustments for chronic renal insufficiency, based on estimated renal function (Cockcroft-Gault, MDRD etc…)</li>
<li>However, accuracy of these equations are limited in severely ill, high-low body mass, prolonged hospitalization</li>
</ul>
<p><span class="math display">\[
CrCl\text{ estimated}=\left(\frac{\left(140-age  \right)\ast \left( Weight, kg \right)}{72\ast SeCr} \right)\ast 0.85 \text{ if female}
\]</span></p>
<ul>
<li>Drug specific guidance for patient on dialysis</li>
</ul>
</section>
<section id="be-careful-about-prematurely-reducing-antibiotic-doses-based-on-serum-creatinine" class="slide level2">
<h2>Be careful about prematurely reducing <br> antibiotic doses based on serum creatinine</h2>
<p><br></p>
<ul>
<li><p>Antibiotic renal dose adjustments in drug labels are based on patients with <u>chronic kidney disease</u></p></li>
<li><p>Renal impairment is <u>acute, not chronic, in up to 50% of patients with infection</u> and frequently <u>resolves within the first 48 hours</u></p></li>
<li><p>Creatine-based equations for estimates of CrCl are based on steady-state conditions, and not as accurate in acute kidney injury</p></li>
<li><p>Decreases in SeCr are delayed with respect to injury resolution</p></li>
<li><p>Renal dose reduction in the first 48 hours of therapy may unnecessarily result in underdosing of antibiotics</p></li>
</ul>

<aside><div>
<p><span class="citation" data-cites="crass2019">(<a href="#/references" role="doc-biblioref" onclick="">Crass et al., 2019</a>)</span></p>
</div></aside></section>
<section id="augmented-renal-clearance" class="slide level2">
<h2>Augmented renal clearance</h2>
<div class="columns">
<div class="column" style="width:30%;">
<p><a href="images/kidney-1.svg" class="lightbox" data-gallery="quarto-lightbox-gallery-23"><img data-src="images/kidney-1.svg" width="200"></a></p>
</div><div class="column" style="width:70%;">
<p><br> <br></p>
<ul>
<li><p>Common causes: “hyperdynamic state” with Gram-negative sepsis, vasoactive medications to support blood pressure large-volume fluid resuscitation</p></li>
<li><p>Most common populations with augmented clearance:</p>
<ul>
<li><p>Younger patients (i.e.&nbsp;trauma)</p></li>
<li><p>Severe burn patients pregnant patients septic patients without renal dysfunction</p></li>
</ul></li>
<li><p><strong>Combined with increased Vd, often leads to inadequate antibiotic exposures</strong></p></li>
</ul>
</div></div>
<p><br></p>
</section>
<section id="pharmacology-of-antimicrobial-therapy" class="slide level2">
<h2>Pharmacology of antimicrobial therapy</h2>
<div class="cell" data-layout-align="default">
<div class="cell-output-display">
<div>
<p></p><figure class=""><p></p>
<div>
<svg width="960" height="480" viewbox="0.00 0.00 582.13 242.40" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" style="; max-width: none; max-height: none; display: block; margin: auto auto auto auto">
<g id="graph0" class="graph" transform="scale(1 1) rotate(0) translate(4 238.4)">
<title>G</title>
<polygon fill="white" stroke="transparent" points="-4,4 -4,-238.4 578.13,-238.4 578.13,4 -4,4"></polygon>
<g id="clust2" class="cluster">
<title>cluster_1</title>
<polygon fill="lightblue" stroke="lightblue" points="282.3,-67.4 282.3,-226.4 566.13,-226.4 566.13,-67.4 282.3,-67.4"></polygon>
<text text-anchor="middle" x="424.22" y="-209.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacodynamics (PD)</text>
</g>
<g id="clust1" class="cluster">
<title>cluster_0</title>
<polygon fill="lightblue" stroke="lightblue" points="8,-109.4 8,-192.4 262.3,-192.4 262.3,-109.4 8,-109.4"></polygon>
<text text-anchor="middle" x="135.15" y="-175.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacokinetics (PK)</text>
</g>
<!-- start -->
<g id="node1" class="node">
<title>start</title>
<polygon fill="white" stroke="white" points="121.73,-156.4 16.09,-156.4 16.09,-120.4 121.73,-120.4 121.73,-156.4"></polygon>
<text text-anchor="middle" x="68.91" y="-134.2" font-family="Lato,Arial,sans-serif" font-size="14.00">Dosing regimen</text>
</g>
<!-- dosing -->
<g id="node2" class="node">
<title>dosing</title>
<polygon fill="white" stroke="white" points="254.55,-159 157.57,-159 157.57,-117.8 254.55,-117.8 254.55,-159"></polygon>
<text text-anchor="middle" x="206.06" y="-142.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="206.06" y="-125.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> time in serum</text>
<text text-anchor="middle" x="122.23" y="-105" font-family="Lato,Arial,sans-serif" font-size="14.00"> </text>
<text text-anchor="middle" x="122.23" y="-88.2" font-family="Lato,Arial,sans-serif" font-size="14.00"> &nbsp;&nbsp;&nbsp;</text>
<text text-anchor="middle" x="122.23" y="-71.4" font-family="Lato,Arial,sans-serif" font-size="14.00"> &nbsp;</text>
<text text-anchor="middle" x="122.23" y="-54.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Absorption </text>
<text text-anchor="middle" x="122.23" y="-37.8" font-family="Lato,Arial,sans-serif" font-size="14.00">Distribution </text>
<text text-anchor="middle" x="122.23" y="-21" font-family="Lato,Arial,sans-serif" font-size="14.00">Metabolism </text>
<text text-anchor="middle" x="122.23" y="-4.2" font-family="Lato,Arial,sans-serif" font-size="14.00">Elimination</text>
</g>
<!-- start&#45;&gt;dosing -->
<g id="edge1" class="edge">
<title>start-&gt;dosing</title>
<path fill="none" stroke="black" d="M121.78,-138.4C130.14,-138.4 138.84,-138.4 147.33,-138.4"></path>
<polygon fill="black" stroke="black" points="147.54,-141.9 157.54,-138.4 147.54,-134.9 147.54,-141.9"></polygon>
</g>
<!-- tissue -->
<g id="node3" class="node">
<title>tissue</title>
<polygon fill="white" stroke="white" points="387.26,-193 292.94,-193 292.94,-151.8 387.26,-151.8 387.26,-193"></polygon>
<text text-anchor="middle" x="340.1" y="-176.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="340.1" y="-159.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> time in tissue</text>
</g>
<!-- dosing&#45;&gt;tissue -->
<g id="edge2" class="edge">
<title>dosing-&gt;tissue</title>
<path fill="none" stroke="black" d="M254.36,-150.58C263.58,-152.95 273.34,-155.47 282.83,-157.91"></path>
<polygon fill="black" stroke="black" points="282.02,-161.32 292.58,-160.42 283.76,-154.54 282.02,-161.32"></polygon>
</g>
<!-- infection -->
<g id="node4" class="node">
<title>infection</title>
<polygon fill="white" stroke="white" points="389.69,-133.8 290.51,-133.8 290.51,-75 389.69,-75 389.69,-133.8"></polygon>
<text text-anchor="middle" x="340.1" y="-117" font-family="Lato,Arial,sans-serif" font-size="14.00">Conc. vs. </text>
<text text-anchor="middle" x="340.1" y="-100.2" font-family="Lato,Arial,sans-serif" font-size="14.00"> time at site of </text>
<text text-anchor="middle" x="340.1" y="-83.4" font-family="Lato,Arial,sans-serif" font-size="14.00"> infection</text>
</g>
<!-- dosing&#45;&gt;infection -->
<g id="edge3" class="edge">
<title>dosing-&gt;infection</title>
<path fill="none" stroke="black" d="M254.36,-126.22C262.85,-124.03 271.8,-121.73 280.56,-119.47"></path>
<polygon fill="black" stroke="black" points="281.54,-122.84 290.35,-116.95 279.8,-116.06 281.54,-122.84"></polygon>
</g>
<!-- PD1 -->
<g id="node5" class="node">
<title>PD1</title>
<polygon fill="yellow" stroke="yellow" points="558.25,-193 425.77,-193 425.77,-151.8 558.25,-151.8 558.25,-193"></polygon>
<text text-anchor="middle" x="492.01" y="-176.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Pharmacological or &nbsp;</text>
<text text-anchor="middle" x="492.01" y="-159.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> toxicological effect</text>
</g>
<!-- tissue&#45;&gt;PD1 -->
<g id="edge4" class="edge">
<title>tissue-&gt;PD1</title>
<path fill="none" stroke="black" d="M387.3,-172.4C396.3,-172.4 405.96,-172.4 415.62,-172.4"></path>
<polygon fill="black" stroke="black" points="415.67,-175.9 425.67,-172.4 415.67,-168.9 415.67,-175.9"></polygon>
</g>
<!-- PD2 -->
<g id="node6" class="node">
<title>PD2</title>
<polygon fill="yellow" stroke="yellow" points="556.52,-125 427.51,-125 427.51,-83.8 556.52,-83.8 556.52,-125"></polygon>
<text text-anchor="middle" x="492.01" y="-108.6" font-family="Lato,Arial,sans-serif" font-size="14.00">Antimicrobal effect </text>
<text text-anchor="middle" x="492.01" y="-91.8" font-family="Lato,Arial,sans-serif" font-size="14.00"> vs. time</text>
</g>
<!-- infection&#45;&gt;PD2 -->
<g id="edge5" class="edge">
<title>infection-&gt;PD2</title>
<path fill="none" stroke="black" d="M389.77,-104.4C398.56,-104.4 407.9,-104.4 417.22,-104.4"></path>
<polygon fill="black" stroke="black" points="417.3,-107.9 427.3,-104.4 417.3,-100.9 417.3,-107.9"></polygon>
</g>
</g>
</svg>
</div>
<p></p></figure><p></p>
</div>
</div>
</div>
</section>
<section id="laws-of-antimicrobial-pharmacodynamics" class="slide level2" data-background-image="images/pd.jpg" data-background-opacity="0.1">
<h2>Laws of antimicrobial pharmacodynamics</h2>
<p><br></p>
<ul>
<li><p><strong>The shape of the antibiotic concentration versus antimicrobial effect curve is important for dosing</strong></p></li>
<li><p>Only free-drug (non-protein bound fraction) is microbiologically active</p></li>
<li><p>A higher MIC will diminish the effect of a fixed dose</p></li>
<li><p>Administering a fixed dose of drug to many patients (even on a mg/kg basis) results in wide variability in exposure</p></li>
</ul>

<aside><div>
<p><span class="citation" data-cites="drusano2004">(<a href="#/references" role="doc-biblioref" onclick="">Drusano, 2004</a>)</span></p>
</div></aside></section>
<section id="how-does-pd-differ-from-mics" class="slide level2 smaller">
<h2>How does PD differ from MICs?</h2>
<div class="columns">
<div class="column" style="width:50%;">
<p><a href="images/MICs.png" class="lightbox" data-gallery="quarto-lightbox-gallery-24"><img data-src="images/MICs.png"></a></p>
<ul>
<li><p>Good indicators of potency</p></li>
<li><p>Tell us nothing about time course of antibiotic activity</p></li>
<li><p>Nothing about dose-response relationship</p></li>
</ul>
</div><div class="column" style="width:50%;">
<p><img data-src="images/PD.png" width="800"><br></p>
<p><br></p>
<p><br></p>
<ul>
<li><p>How does the rate and extent of bacterial killing by an antibiotic change at concentrations near and above the MIC?</p></li>
<li><p>The shape of the curve affects drug dosing strategies</p></li>
</ul>
</div></div>
</section>
<section id="how-to-define-concentration-time-kill-effect-curves" class="slide level2 smaller">
<h2>How to define concentration-time-kill effect curves</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/tkcurve1.png" class="lightbox" data-gallery="quarto-lightbox-gallery-25"><img data-src="images/tkcurve1.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
</section>
<section id="interpreting-time-kill-curves" class="slide level2 smaller">
<h2>Interpreting time-kill curves</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/tkcurve2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-26"><img data-src="images/tkcurve2.png" class="quarto-figure quarto-figure-center" width="700"></a></p>
</figure>
</div>

<aside><div>
<p>Common questions addressed:</p>
<ul>
<li><p>Did the rate and extent of killing increase at higher MIC multiples?</p></li>
<li><p>What is the multiple of MIC where killing was maximized?</p></li>
<li><p>Did the antibiotic achieve bacteriostatic (2-log<sub>10</sub>) or bactericidal (3-log<sub>10</sub>) reductions in CFU?</p></li>
</ul>
<p><span class="citation" data-cites="craig_1998">(<a href="#/references" role="doc-biblioref" onclick="">Craig, 1998</a>)</span></p>
</div></aside></section>
<section id="post-antibiotic-effect-pae" class="slide level2 smaller">
<h2>Post antibiotic effect (PAE)</h2>
<p><a href="images/PAE.png" class="lightbox" data-gallery="quarto-lightbox-gallery-27"><img data-src="images/PAE.png" width="900"></a></p>

<aside><div>
<p><span class="citation" data-cites="craig_1998">(<a href="#/references" role="doc-biblioref" onclick="">Craig, 1998</a>)</span></p>
</div></aside></section>
<section id="how-do-you-translate" class="slide level2 smaller">
<h2>How do you translate?</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/translate.png" class="lightbox" data-gallery="quarto-lightbox-gallery-28"><img data-src="images/translate.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
</section>
<section id="integration-of-pkpd-concepts" class="slide level2" data-fig-align="center" width="800">
<h2>Integration of PK/PD concepts</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/integrate.png" class="lightbox" data-gallery="quarto-lightbox-gallery-29"><img data-src="images/integrate.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>
</section>
<section id="common-pkpd-indices" class="slide level2 smaller">
<h2>Common PK/PD indices</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/pkpdindice.png" class="lightbox" data-gallery="quarto-lightbox-gallery-30"><img data-src="images/pkpdindice.png" class="quarto-figure quarto-figure-center" width="900"></a></p>
</figure>
</div>

<aside><div>
<p>AUC = Area under the concentration–time curve; MIC = Minimum Inhibitory Concentration; Cmax = Maximum or peak plasma concentration; Cmin = Minimum or trough plasma concentration</p>
</div></aside></section>
<section id="dose-fractionization-study" class="slide level2 smaller">
<h2>Dose fractionization study</h2>
<p><a href="images/fraction.png" class="lightbox" data-gallery="quarto-lightbox-gallery-31"><img data-src="images/fraction.png"></a></p>
</section>
<section id="dose-fractionization-study-interpretation" class="slide level2 smaller">
<h2>Dose fractionization study-interpretation</h2>
<p><a href="images/fraction_interpret.png" class="lightbox" data-gallery="quarto-lightbox-gallery-32"><img data-src="images/fraction_interpret.png"></a></p>
</section>
<section id="example-of-dose-fractionization-study-results" class="slide level2">
<h2>Example of dose fractionization study results</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/df1.png" class="lightbox" data-gallery="quarto-lightbox-gallery-33"><img data-src="images/df1.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="forrest1993 craig_1998">(<a href="#/references" role="doc-biblioref" onclick="">Craig, 1998</a>; <a href="#/references" role="doc-biblioref" onclick="">Forrest et al., 1993</a>)</span></p>
</div></aside></section>
<section id="ciprofloxacin-example" class="slide level2">
<h2>Ciprofloxacin example</h2>
<div class="columns">
<div class="column" style="width:50%;">
<p><a href="images/df_tk.png" class="lightbox" data-gallery="quarto-lightbox-gallery-34"><img data-src="images/df_tk.png" width="600"></a></p>
</div><div class="column" style="width:50%;">
<p><br></p>
<p><a href="images/dfcipro.png" class="lightbox" data-gallery="quarto-lightbox-gallery-35"><img data-src="images/dfcipro.png" width="600"></a></p>
</div></div>

<aside><div>
<p><span class="citation" data-cites="craig_1998">(<a href="#/references" role="doc-biblioref" onclick="">Craig, 1998</a>)</span></p>
</div></aside></section>
<section id="from-mice-to-humans" class="slide level2">
<h2>From mice to humans</h2>
<p><br></p>
<p><br></p>
<div class="columns">
<div class="column" style="width:30%;">
<p><a href="images/dfcipro.png" class="lightbox" data-gallery="quarto-lightbox-gallery-36"><img data-src="images/dfcipro.png" width="400"></a></p>
</div><div class="column" style="width:70%;">
<p><a href="images/ciproexample3.png" class="lightbox" data-gallery="quarto-lightbox-gallery-37"><img data-src="images/ciproexample3.png" width="900"></a></p>
</div></div>

<aside><div>
<p><span class="citation" data-cites="forrest1993">(<a href="#/references" role="doc-biblioref" onclick="">Forrest et al., 1993</a>)</span></p>
</div></aside></section>
<section id="pkpd-parameters-predictive-in-animals-and-humans" class="slide level2 smaller">
<h2>PK/PD parameters predictive <br> in animals and humans</h2>
<table class="caption-top" style="width:98%;">
<colgroup>
<col style="width: 11%">
<col style="width: 13%">
<col style="width: 24%">
<col style="width: 22%">
<col style="width: 25%">
</colgroup>
<thead>
<tr class="header">
<th>Antibiotic class</th>
<th>Optimal Pk/PD index</th>
<th>PK/PD magnitude for bacterial killing</th>
<th>PK/PD index for clinical efficacy</th>
<th>PK/PD index for resistance suppression</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Aminoglycosides</td>
<td>AUC<sub>0-24</sub>/MIC</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</section>
<section id="advantages-of-animal-models-for-pkpd-studies" class="slide level2 smaller">
<h2>Advantages of animal models for PK/PD studies</h2>
</section>
<section id="limitations-of-animal-models-for-pkpd-studies" class="slide level2 smaller">
<h2>Limitations of animal models for PK/PD studies</h2>
</section>
<section id="in-vitro-hollow-fiber-models" class="slide level2 smaller">
<h2>In vitro hollow-fiber models</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/hfmodel.png" class="lightbox" data-gallery="quarto-lightbox-gallery-38"><img data-src="images/hfmodel.png" class="quarto-figure quarto-figure-center" width="600"></a></p>
</figure>
</div>
<ul>
<li><p>Simulate antibiotic dosing regimens in vivo</p></li>
<li><p>Bacterial inocula is retained in dialysis cartridge.</p>
<ul>
<li><p>Media containing drug is pumped through cartridge.</p></li>
<li><p>The pump rate simulates antibiotic half-life</p></li>
</ul></li>
<li><p>Study antibiotic performance over a wide range of inocula (important for resistance studies)</p></li>
<li><p>No impact of protein binding, immune system, etc</p></li>
</ul>
</section>
<section id="in-vitro-hollow-fiber-models-1" class="slide level2 smaller">
<h2>In vitro hollow-fiber models</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/HFmodel2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-39"><img data-src="images/HFmodel2.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p>Image: Roger nation, Ph.D., Monash University, Melbourne, Austraila</p>
<section id="section" class="slide level2">
<h2></h2>
</section>
</div></aside></section>
<section id="laws-of-pharmacodynamics" class="slide level2" data-background-image="images/capillary.png" data-background-opacity="0.1">
<h2>Laws of pharmacodynamics</h2>
<p><br></p>
<ul>
<li><p>The shape of the antibiotic concentration versus antimicrobial effect curve is important for dosing</p></li>
<li><p><strong>Only free-drug (non-protein bound fraction) is microbiologically active</strong></p></li>
<li><p>A higher MIC will diminish the effect of a fixed dose</p></li>
<li><p>Administering a fixed dose of drug to many patients (even on a mg/kg basis) results in wide variability in exposure</p></li>
</ul>

<aside><div>
<p><span class="citation" data-cites="drusano2004">(<a href="#/references" role="doc-biblioref" onclick="">Drusano, 2004</a>)</span></p>
</div></aside></section>
<section id="references" class="slide level2 smaller scrollable">
<h2>References</h2>
<p><br></p>
<p>Unless otherwise cited, all figures were created using www.biorender.com</p>
<p><br></p>
<div class="quarto-auto-generated-content">
<div class="footer footer-default">

</div>
</div>
<div id="refs" class="references csl-bib-body" data-entry-spacing="0" role="list">
<div id="ref-craig_1998" class="csl-entry" role="listitem">
Craig WA. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and aen. Clinical Infectious Diseases 1998;26:1–10. <a href="https://doi.org/10.1086/516284">https://doi.org/10.1086/516284</a>.
</div>
<div id="ref-crass2019" class="csl-entry" role="listitem">
Crass RL, Rodvold KA, Mueller BA, Pai MP. Renal Dosing of Antibiotics: Are We Jumping the Gun? Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019;68:15961602. <a href="https://doi.org/10.1093/cid/ciy790">https://doi.org/10.1093/cid/ciy790</a>.
</div>
<div id="ref-drusano2004" class="csl-entry" role="listitem">
Drusano GL. Antimicrobial pharmacodynamics: critical interactions of ’bug and drug’. Nature Reviews Microbiology 2004;2:289–300. <a href="https://doi.org/10.1038/nrmicro862">https://doi.org/10.1038/nrmicro862</a>.
</div>
<div id="ref-forrest1993" class="csl-entry" role="listitem">
Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ. <a href="https://www.ncbi.nlm.nih.gov/pubmed/8517694">Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients</a>. Antimicrobial Agents and Chemotherapy 1993;37:10731081.
</div>
<div id="ref-gilbert2006" class="csl-entry" role="listitem">
Gilbert DN. Urinary tract infections in patients with chronic renal insufficiency. Clinical journal of the American Society of Nephrology: CJASN 2006;1:327–31. <a href="https://doi.org/10.2215/CJN.01931105">https://doi.org/10.2215/CJN.01931105</a>.
</div>
<div id="ref-huttner2020" class="csl-entry" role="listitem">
Huttner A, Bielicki J, Clements MN, Frimodt-Møller N, Muller AE, Paccaud J-P, et al. Oral amoxicillin and amoxicillin<span></span>clavulanic acid: Properties, indications and usage. Clinical Microbiology and Infection 2020;26:871–9. <a href="https://doi.org/10.1016/j.cmi.2019.11.028">https://doi.org/10.1016/j.cmi.2019.11.028</a>.
</div>
<div id="ref-kothekar2020" class="csl-entry" role="listitem">
Kothekar AT, Divatia JV, Myatra SN, Patil A, Nookala Krishnamurthy M, Maheshwarappa HM, et al. Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria. Annals of Intensive Care 2020;10:4. <a href="https://doi.org/10.1186/s13613-019-0622-8">https://doi.org/10.1186/s13613-019-0622-8</a>.
</div>
<div id="ref-lodise2011" class="csl-entry" role="listitem">
Lodise TP, Sorgel F, Melnick D, Mason B, Kinzig M, Drusano GL. Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia. Antimicrobial Agents and Chemotherapy 2011;55:1606–10. <a href="https://doi.org/10.1128/AAC.01330-10">https://doi.org/10.1128/AAC.01330-10</a>.
</div>
<div id="ref-macgregor1997" class="csl-entry" role="listitem">
MacGregor RR, Graziani AL. Oral administration of antibiotics: A rational alternative to the parenteral route. Clinical Infectious Diseases 1997;24:457–67. <a href="https://doi.org/10.1093/clinids/24.3.457">https://doi.org/10.1093/clinids/24.3.457</a>.
</div>
<div id="ref-theuretzbacher2012" class="csl-entry" role="listitem">
Theuretzbacher U. Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer. Clinical Infectious Diseases 2012;54:1785–92. <a href="https://doi.org/10.1093/cid/cis210">https://doi.org/10.1093/cid/cis210</a>.
</div>
<div id="ref-wald-dickler2022" class="csl-entry" role="listitem">
Wald-Dickler N, Holtom PD, Phillips MC, Centor RM, Lee RachaelA, Baden R, et al. Oral is the new IV. Challenging decades of blood and bone infection dogma: A systematic review. The American Journal of Medicine 2022;135:369–379.e1. <a href="https://doi.org/10.1016/j.amjmed.2021.10.007">https://doi.org/10.1016/j.amjmed.2021.10.007</a>.
</div>
</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="Lecture1_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="Lecture1_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-chalkboard/plugin.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/multiplex/socket.io.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/multiplex/multiplex.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-pointer/pointer.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="Lecture1_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': false,
'previewLinksAuto': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleChalkboard(event)\"><kbd>b</kbd> Toggle Chalkboard</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleNotesCanvas(event)\"><kbd>c</kbd> Toggle Notes Canvas</a></li>\n<li class=\"slide-tool-item\" data-item=\"6\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.downloadDrawings(event)\"><kbd>d</kbd> Download Drawings</a></li>\n<li class=\"slide-tool-item\" data-item=\"7\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'chalkboard': {"buttons":true},
'multiplex': {"secret":"17161910004088916252","id":"531ecee0877a6fd0","url":"https://reveal-multiplex.glitch.me/"},
'pointer': {"key":"q","color":"red","pointerSize":16,"alwaysVisible":false},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: true,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: 'c/t',

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'fade',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'fast',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, RevealChalkboard, RevealPointer, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const onCopySuccess = function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      }
      const getTextToCopy = function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
        text: getTextToCopy
      });
      clipboard.on('success', onCopySuccess);
      if (window.document.getElementById('quarto-embedded-source-code-modal')) {
        // For code content inside modals, clipBoardJS needs to be initialized with a container option
        // TODO: Check when it could be a function (https://github.com/zenorocha/clipboard.js/issues/860)
        const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
          text: getTextToCopy,
          container: window.document.getElementById('quarto-embedded-source-code-modal')
        });
        clipboardModal.on('success', onCopySuccess);
      }
        var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
        var mailtoRegex = new RegExp(/^mailto:/);
          var filterRegex = new RegExp('/' + window.location.host + '/');
        var isInternal = (href) => {
            return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
        }
        // Inspect non-navigation links and adorn them if external
     	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
        for (var i=0; i<links.length; i++) {
          const link = links[i];
          if (!isInternal(link.href)) {
            // undo the damage that might have been done by quarto-nav.js in the case of
            // links that we want to consider external
            if (link.dataset.originalHref !== undefined) {
              link.href = link.dataset.originalHref;
            }
          }
        }
      function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
        const config = {
          allowHTML: true,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start',
        };
        if (contentFn) {
          config.content = contentFn;
        }
        if (onTriggerFn) {
          config.onTrigger = onTriggerFn;
        }
        if (onUntriggerFn) {
          config.onUntrigger = onUntriggerFn;
        }
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note) {
            return note.innerHTML;
          } else {
            return "";
          }
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    <script>var lightboxQuarto = GLightbox({"closeEffect":"zoom","selector":".lightbox","loop":false,"openEffect":"zoom","descPosition":"bottom"});
    (function() {
      let previousOnload = window.onload;
      window.onload = () => {
        if (previousOnload) {
          previousOnload();
        }
        lightboxQuarto.on('slide_before_load', (data) => {
          const { slideIndex, slideNode, slideConfig, player, trigger } = data;
          const href = trigger.getAttribute('href');
          if (href !== null) {
            const imgEl = window.document.querySelector(`a[href="${href}"] img`);
            if (imgEl !== null) {
              const srcAttr = imgEl.getAttribute("src");
              if (srcAttr && srcAttr.startsWith("data:")) {
                slideConfig.href = srcAttr;
              }
            }
          } 
        });
      
        lightboxQuarto.on('slide_after_load', (data) => {
          const { slideIndex, slideNode, slideConfig, player, trigger } = data;
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(slideNode);
          }
        });
      
      };
      
    })();
              </script>
    

</body></html>